CA2050057A1 - Interferant eliminating biosensors - Google Patents
Interferant eliminating biosensorsInfo
- Publication number
- CA2050057A1 CA2050057A1 CA002050057A CA2050057A CA2050057A1 CA 2050057 A1 CA2050057 A1 CA 2050057A1 CA 002050057 A CA002050057 A CA 002050057A CA 2050057 A CA2050057 A CA 2050057A CA 2050057 A1 CA2050057 A1 CA 2050057A1
- Authority
- CA
- Canada
- Prior art keywords
- oxidase
- peroxidase
- electrode
- biosensor
- catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/002—Electrode membranes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/817—Enzyme or microbe electrode
Abstract
ABSTRACT OF THE DISCLOSURE
Interferant eliminating analyte sensors and sensing process prevent erroneous assays. Glucose electrodes were coated with an oxidizing enzyme (peroxidase) which allows hydrogen peroxide to selectively oxidize ascorbate, urate, bilirubin, and acetaminophenol in the presence of glucose. Hydrogen peroxide may be added to the assayed solution or generated in situ. The oxidizing enzyme was prevented from causing undesired reduction currents at the glucose electrode by preventing contact of the oxidizing enzyme with the glucose electrode, or by increasing the applied voltage.
Interferant eliminating analyte sensors and sensing process prevent erroneous assays. Glucose electrodes were coated with an oxidizing enzyme (peroxidase) which allows hydrogen peroxide to selectively oxidize ascorbate, urate, bilirubin, and acetaminophenol in the presence of glucose. Hydrogen peroxide may be added to the assayed solution or generated in situ. The oxidizing enzyme was prevented from causing undesired reduction currents at the glucose electrode by preventing contact of the oxidizing enzyme with the glucose electrode, or by increasing the applied voltage.
Description
~5.~5~
1 ) rl-ld o~ ~ Inv-n~Q~
T~i8 invcntlon r~lates to an i~prov~d sen80r an~ aensLng 8yStR3 ~or a~saylnq th~ concentratlo~ of an an~lyt- in a solu~lon. More psrticul~rly, th~ senaor and 3~n~tng 6y8t2m oli~inat~ int-rf~r~nt~ by ~-lectivoly ox~d$zinq thQ interfer~nt~
b4~0r- ~uch lntcr~erant~ int~r~-r~ su~etanti~lly with the a86ay.
1 ) rl-ld o~ ~ Inv-n~Q~
T~i8 invcntlon r~lates to an i~prov~d sen80r an~ aensLng 8yStR3 ~or a~saylnq th~ concentratlo~ of an an~lyt- in a solu~lon. More psrticul~rly, th~ senaor and 3~n~tng 6y8t2m oli~inat~ int-rf~r~nt~ by ~-lectivoly ox~d$zinq thQ interfer~nt~
b4~0r- ~uch lntcr~erant~ int~r~-r~ su~etanti~lly with the a86ay.
2) ~1~1_~
Glucose i~ typically assayed by d~tQcting ~he concentration o~ gluco~e at ¢nzy~e ~loctro~e~ uslng glucos- oxlda6e. 30cau~-o~ ov rla~pln~ oxidation potential~, exi~ting onzym- electrod~
. ~n-or~ c~nnot dlccriminate ~ctwesn glu¢os- and othsr al-ctrooxldlzable ~p-cie~ ~hor-R~t-r ~int-r~rantc") ~uch a~
a-co~bat-, urat-, bi~irubin, cy-t-ine, and ac-ta~inoph~nol.
Con~-gu~ntly, the~- int-r~-ring species, and oth-r ~pooles whiah alco h-ve overl~pping axidation pot~nti~l~, pr~vQnt th~ ~ccurat-analy-i~ o~ gluco~ in blood eampl-~.
Por-on~ skill-d $n tne art hav ~arc~d ~or way- to provo~t ~h lnt~ r~ntJ ~ron ~ ct~ny th- ac~urato an~ o~ gluco~e 2S in blood Jolutlon-. U.~. p~t~nt 4,098,574 to Dapp~n app~ar- to dl~clo~o t~t int-r~orant- Or rluorid- ion wlth gluco-- an~lysis i p4r~0r~ d ln int-qr~l ~ultilay~r 10~4ntc c~n b- r~duc~d or .. ll~in~t-d by but~-rlnq th~ ro~gont oo~po-ition cont~lned th-r-in to ~ p~ b~t~ n 4~5 ~nd 6Ø U.S. pat-nt 4,247,297 to B-rti ~t al. ap~4~ro to cl~im a t-ct ~y~tea ~highly r~latant to intor~-ring r d uoing ~ub~t~nco~ t~ough t~- u~o o~ ~ ta~t m-~n-compr~Jing ~ hy~r~zon- and 8-amlno-1-n~phthol-~,7-dl~ul~onlc , acl~.
Glucose i~ typically assayed by d~tQcting ~he concentration o~ gluco~e at ¢nzy~e ~loctro~e~ uslng glucos- oxlda6e. 30cau~-o~ ov rla~pln~ oxidation potential~, exi~ting onzym- electrod~
. ~n-or~ c~nnot dlccriminate ~ctwesn glu¢os- and othsr al-ctrooxldlzable ~p-cie~ ~hor-R~t-r ~int-r~rantc") ~uch a~
a-co~bat-, urat-, bi~irubin, cy-t-ine, and ac-ta~inoph~nol.
Con~-gu~ntly, the~- int-r~-ring species, and oth-r ~pooles whiah alco h-ve overl~pping axidation pot~nti~l~, pr~vQnt th~ ~ccurat-analy-i~ o~ gluco~ in blood eampl-~.
Por-on~ skill-d $n tne art hav ~arc~d ~or way- to provo~t ~h lnt~ r~ntJ ~ron ~ ct~ny th- ac~urato an~ o~ gluco~e 2S in blood Jolutlon-. U.~. p~t~nt 4,098,574 to Dapp~n app~ar- to dl~clo~o t~t int-r~orant- Or rluorid- ion wlth gluco-- an~lysis i p4r~0r~ d ln int-qr~l ~ultilay~r 10~4ntc c~n b- r~duc~d or .. ll~in~t-d by but~-rlnq th~ ro~gont oo~po-ition cont~lned th-r-in to ~ p~ b~t~ n 4~5 ~nd 6Ø U.S. pat-nt 4,247,297 to B-rti ~t al. ap~4~ro to cl~im a t-ct ~y~tea ~highly r~latant to intor~-ring r d uoing ~ub~t~nco~ t~ough t~- u~o o~ ~ ta~t m-~n-compr~Jing ~ hy~r~zon- and 8-amlno-1-n~phthol-~,7-dl~ul~onlc , acl~.
3~ ~r-onz sklllod ln th- art hav- ~loo ~ttenpt~d to d~ign hlg~ly p-citlc J-n~ors, p~rtl? in an ~ort to r~duc- th~ ct ~' 2~5~
of interferants. U.S. patent 4,776,944 to Janata et al. appears to disclose a chemical selective sensor system which utilizes ad~ittance modul~tion to detect the presence of chemicals in a fluid. Commercial variations of the glucose sensors have also utilized filterinq membranes and electrostatic repulsion membranes to inhibit interferants f-om reaching the analyte sensing layer.
Despite the above described improvements, persons skilled in the art have not yet adequately solved the inaccuracy problems caused by interferants.
SUHXARY OF THE INVE~TION
lS A general object of this inventlon is to provide i~proved sensors and sensing methods wherein the effect of interferants is minimized or eliminated by oxidizing the interferants before they affect the accuracy of the assay. The problems in the prior art are solved by a novel sensor for detecting analyte concentration in the solution, comprising a sensing element with a sensing surface, and wherein the sensing surface is substantially surrounded or covered by a catalyst containing layer capable of oxidizing a plurality of interferants in the presence of an oxidant. In the examples, peroxidase was the catalyst and hydrogen peroxide was the oxidant. The sensing element comprises an electrode and an analyte sensing layer in electrical contact with the electrode. T~e analyte sensing layer comprises an enzyme which comprises an oxidoreductase. Examples of suitable oxidoreductases include glucose oxidase for glucose analysis, lactate oxidase for lactic acid analysis, etc.
One form of the ~ensor comprises the electrode described above, further comprising a catalyst containing layer immobilized on top of the first layer. The catalyst containing layer operates in the presence of an oxidant to oxidize the interferant 2~a~7 c~mpounds prior to those compounds reaching the sensing elemenl.
In thls manner the sensing element is protected fro~ the interfering influence of the interferants.
Since the catalyst containing laye~ may itself nega~ively affect the assay, it is advantageous to prevent the catalyst containing layer from interfering with the sensing elemen.. One method to prevent this interference entails adjusting the operating conditions such that the catalyst containing layer will no longer interfere. Alternately, a thin barrier layer between the analyte sensing layer and the catalyst containing layer may inhibit the catalyst contair,ing layer from permeating the analyte sensing layer and thus inhibiting the catalyst containing layer from coming into contact with the analyte sensing elements.
Still further, the analyte sensing layer may be crosslinked to make it less permeable to the catalyst containing layer, thus inhibi~ing the catalyst containing layer from coming into contact with the analyte sensing elements.
Since the oxidant itself may be undesirable in some circumstances, a methodology describing in sLtu production of the oxidant is provided. In this manner, the oxidant may be produced ~
by a separate enzyme in a separate layer, or by the same en2yme used in the analyte sensing layer. The oxidant producing enzyme may be mixed with the analyte sensing layer, with the catalyst containing layer, or may itself be a separate layer.
B~IEF DE8CRIPTION OF T~ DRAWING8 .
Figure l is a schematic view of an electrochemical glucose biosensor having a analyte (glucose) sensing layer on top of the electrode surface (layer I).
- Figure 2 is a schematic view of an electrochemical glucose biosensor with a catalyst containing layer that eliminates the 2~53~)~7 inte_ferants~ This device has a peroxidase catalyst containi~q layer covering the glucose sensin~ element (layer II).
Figure 3 is a schematic view of an electrochemical glucose biosensor with an catalyst containing layer that eliminates interferants and an oxidant (hydrogen peroxide) generating layer.
Ihis device has a layer of lactate oxidase (layer III) covering the catalyst containing layer. The purpose of layer III is to use lactic acid and oxygen to ~enerate the hydrogen peroxide needed in the catalyst containing layer.
Figure 4 shows the results of a measurement performed with an electrode of the type described in Example 1. The signals (current as a function of time) obtained upon additions of ascorbate (0.1 millimolar ("mM")) and glucose ~2 mM) are shown in "a" in the absence of hydrogen peroxide, and shown in "b" with hydrogen peroxide (O.1 mM) added.
Figure 5 shows the results of a measurement performed with an electrode of the type described in Example 1. The signals (current as a function of time) obtained upon additions of Tylenol (acetaminophen, 0.1 mM) and glucose (2 mM) are shown in "a" in the absence of hydrogen peroxide, and shown in "b" with hydrogen peroxide (0.1 mM) added.
Figure 6 is a schematic diagram of a multilayer electrode with an osmium based glucose sensing layer, and a barrier layer between the catalyst containing layer (interferant eliminating layer - i.e. immobilized peroxidase) and the analyte (glucose) sensing layer.
DE8CRIPT~ON OF T~E PREFERRED EMBODIMENT8 The device is an electrochemical analyte sensor composed of two or more layers of catalysts and electron relays (or 2 ~ 5 ~
~ediators) covering a solid electrode material. In the context of this applicatlon "analyte~ si~ply me2ns a substance being analyzed, detected, or measured in some manner (in the Examples, glucose is the analyte). Similarly, an "interferant" is a substance that interferes in some manner with any desired analyzation, detection, or measurement process.
The preferred electrode material is glassy carbon but it may be any other electrode material such as graphite, platinum, pal~adium, tin oxide, conducting organic salts, etc.. Typically, a wire electrically contacts with the electrode material.
Various layers of material are coated on the exposed surface of the electrode material. In some instances the electrode material itself is able to sense and detect the analyte but in most cases a special sensinq layer or a chemical modification has to be applied to the electrode material.
The analyte sensing layer (layer I in Figures 1, 2 or 3) contains the sensing elements for the particular analyte and is in close contact with the electrode material. For the purposes of this application it is intended that the phrase "analyte sensing layer" be interpreted broadly to include the necessary ~
sensing elements to detect and send a signal useful for analyzing the analyte. Usually this layer contains an enzyme that is in electrical contact with the electrode through electron relays incorporated in the layer or through diffusing redox mediators.
Alternatively, instead of free enzymes this layer may include cells or tissues which contain enzymes. Any known methodology may be used to bring the analyte sensing layer into electrochemical contact with the electrode. One such ~ethod is described in U.S. patent 4,758,232 to Davis et al.
Suitable analyte sensing layer enzymes are oxidoreductases such as dehydrogenases-or oxidases. Examples of suitable enzymes are glucose oxidase for glucose analysis, lactate oxidase for ~5~ 7 laclic acld analys~s, xanthine oxidase for xanthine analysis, c~olesterol oxidase for cholesterol analysis, pyruvate oxidase for pyruvic acid analysis, L-amino acid oxidases for L-ar~ino acid analysis, D-amino acid oxidases for D-amino acid analysis, alcohol oxidase for alcohol analysis, urease for urea analysis, glycollate oxidase for glycollate analysis, sarcosine oxidase for sarcosine analysis, and other similar enzymes. In the detailed description of the preferred embodiment, glucose oxidase (GOD) is used for the analysis of glucose.
Suitable mediators are electrochemically active compounds such as metal ions, conducting organic salts, quinones and their derivatives, organometallic complexes such as ferrocenes ar.d their derivatives, or polypyridine complexes of transition metals and their derivatives. The same type of compounds that will attach to an enzyme shell and make it electrically conductive will behave as electron relays. In the detailed description of the preferred embodiment a redox polymer based on a poly(vinylpyridine) complex of Osmium bis(bipyridine)chloride is the electron relay. This polymer is brought into close contact with the enzyme and the electrode surface using a crosslinking agent, poly(ethylene glycol) diglycidyl ether and forming an ~
epoxy redox gel.
The catalyst containing layer of the device contains the interferant eliminating elements. The basic component of this layer is a catalyst capable of mediating the following reaction:
H2O2 + AH2 catalY~t ~ 2H2O + A
In this general reaction AH2, the hydrogen donor, is a~
interfering compound and is oxidized by hydrogen peroxide to "A" -- that is, to a noninterfering compound that is no longer substantially electrochemically active. After oxidation the noninterfering compound "A" may diffuse to the analyte sensing 2 ~ n s ~
C~i`5 layer but does not interfer with the because compound "A" ls no longer electrochemically a~tive. The catalyst may ~e a natural enzyme of the peroxidase type such as horseradish peroxidase or a synthetic or semisynthetic catalyst such as some model compound for peroxidase (for example, Iron (III) porphyrins). In the detailed description of the preferred embodiment horseradish peroxidase (PO3) is used as the catalyst.
POD is an enzyme that works weil as a catalyst for the above equation. The POD enzy~e has a low specificity for the hydrogen donor (AX2). A large number of compounds including phenols, aminophenols, diamines, indophenols, leucodyes, ascorbate and amino acids are active as such. More importantly, interferants present in physiological fluids such as ascorbate, urate, acetaminophen, bilirubin, or cysteine are rapidly oxidized by hydrogen peroxide in the presence of POD. Thus a POD containing layer will eliminate these compounds from the electrode vicinity when exposed to H2O2. It is anticipated that any other interfering compound oxidized by hydrogen peroxide in the presence of a suitable catalyst will be promptly removed using this catalyst.
Optimally, the catalyst should cover the analyte sensing layer in such a way that the interferants will come in contact with the catalyst before reaching the analyte sensing layer (see Figure 2). The catalyst may be positioned to cover the analyte sensing layer in this manner using two methods:
(l) using a soluble catalyst contained near the first layer by a dialysis membrane, or (2) using an insolubilized catalyst that coats the analyte sensing layer.
2 ~ 1.5 7 In ~ethod (2), the ca~alyst may be ~ttached to an in~oluble mat~ix or it may be crosslinked with a crosslinking agent formin~
a gel-like structure that is no longer soluble. In the case of the peroxidase type enzymes, protein crosslinking agents such as bifunctional or polyfunctional reagents may be used.
BifunctLonal reagents are used to insolubilize enzymes by intermolecular crosslinking. Crosslinking agents suitable for immobilizing enzymes include glutaraldehyde, cyanogen bromide, periodate, or cyanuric chloride. In the detailed description of the preferred embodiment, horseradish peroxidase (POD) is crosslinked by two alternative methods:
tl) using glutaraldehyde as a crosslinking agent, or (2) oxidation of the oligosaccharide groups in the POD
glycoenzyme with NaIO4, followed by coupling of the - aldehydes formed to hydrazide groups in a polyacrylamide matrix to form hydrazones.
When the interfering compound reaches the catalyst containing layer (layer II) it is oxidized by hydrogen peroxide, thus preventing it from reaching the analyte sensing layer (layer ~
I) and its subsequent electrochemical detection. Hydrogen peroxide is present in one of two ways:
(1) it may be added to the assayed solution, or (2) it may be produced in situ by an enzyme of the oxidase class according to the following equation:
substrate + 2 oxldase ~ oxidized substrate + H2O2 One or more enzymes capable of producing hydrogen peroxide may be included in the H2O2 generating layer as long as appropriate 2~50~57 corresponding substrates are present in the analyzed sample.
Exa~ples of suitable enzymes are glucose oxidase with glucose as the substrate, lactate oxidase with lactic acid as the substrate, xanthine oxidase with xanthine as the substrate, pyruvate oxidase with pyruvate as the substrate, amino acid oxidase with amino acids as the substrates, choline oxidase with choline as the substrate, alcohol oxidase with alcohol as the substrate, ascorbate oxidase with ascorbate as the substrate, urate oxidase with urate as the substrate, aldehyde oxldase with aldehyde as the substrate, sarcosine oxidase with sarcosine as the substrate, etc.
The hydrogen peroxide generating enzyme may be the same enzyme that is being used in the analyte sensing layer as the analyzing enzvme. For example, in the case of a glucose sensor, part of the glucose oxidase will mediate the oxidation of glucose by the electrode through the electron relays, thus providing for the analysis of glucose. The remaining glucose oxidase will mediate the oxidation of glucose by oxygen, thus generating hydrogen peroxide that will be subsequently used in the catalyst containing layer for elimination of the interferants.
This hydrogen peroxide generating enzyme will be contained in a third layer (Figure 3, layer III) and/or it can be mixed together with the catalyst containing layer, or in the analyte sensing layer. The hydrogen peroxide generating enzyme is preferrabIy located near the interferant eliminating catalyst.
This enzyme also may be used as a soluble enzyme contained by a - membrane or as an insoluble enzyme attached to the previous layers. In the detailed description of the preferred embodiment (Example 3) lactate oxidase is used as the hydrogen peroxide generating enzyme according to the following equation:
lactate lactate + 2 oxida~e > pyrUvate + ~{22 2~ 357 In this exa~ple lactate oxidase (LOD) is iN~o~ilized on top of ~he peroxidase layer ~sing glutaraldehyde as the crosslinking reagent.
The multilayer electrodes prepared in this way may be used for all the different kinds of electrochemical sensing methods.
Amperometric, potentiometric, conductimetric or impidi~etric devices as well as i~munoelectrodes can benefit from the use of the interferant elimlnating layers. For the purpose of demonstration the electrodes are used as an amperometric sensin~
device.
Mea~urements are performed in a medium containing an electrolyte and using a three electrode configuration: the multilayer electrode is used as the working electrode, saturated calomel electrode (SCE) or Ag/AgCl is used as a reference electrode, and a metal wire is used as the counter elec.rode.
Alternatively a two electrode configuration may be used (for instance, with Ag/AgCl as both the reference and counter electrodes).
In the detailed description of the preferred embodiment the -multilayer electrode is used as the working electrode, a saturated calomel electrode (SCE) is used as the reference electrode, and a platinum wire is used as the counter electrode in a glass cell containing an electrolyte.
The cell may contain the analyzed sample or this sample may be injected into the cell at a later time. An electrochemical potential is applied to the working electrode with respect to the reference electrode and the current flowing is measured as a function of time. The choice of the electrochemical potential is dependent upon the mediator or electron relay used, as well as the enzyme properties.
The measured current is generally proportional to the concentration of the species being oxidized. When the (interferant eli~inating) catalyst containing layer is no.
active, both the analyte and the interfering species are being s oxidized. Thus the measured current is proportional to both concentrations and the readlng is a false reading. When the catalyst containing layer is active, the interferants are enzymatically oxidized in the catalyst containing layer and do not reach the analyte sensing layer. In the latter case the current being measured is proportional only to the analyte concentration.
Under certain operating conditions the peroxidase enzyme (or the alternative catalyst) may mediate the electrochemical reduction of hydrogen peroxide. This electrochemical reaction is also mediated by the same electron relays that are used in the analyte sensinq element (layer I). This process will result in a reduction current superimposed cn the oxidation current of the analyte and the net current will no longer be proportional to the analyte concentration. This is an undesired situation and it may be prevented in one of the two methods:
(1) by making the potential of the working electrode more oxidative in such a way that the reduction process will no longer proceed; while the oxidations will still proceed.
(2) by preventing electrical contact between the catalyst (peroxidase) and the electron relays.
Preventing electrical contact as in method (2) above may be achieved by either:
(1) applying a thin electrically insulating barrier layer between the analyte sensing layer and the catalyst containing layer. This barrier may be cast from a variety of film or 2 ~ 1 .5 ~1 me~brane for~ing polymers such as cellulose acetate or other cellulose derivatives, polycarbonates, or perfluorinated r~embranes, etc. Figure 6 shows a schematic diagram of a multilayer electrode with an osmium based glucose sensin~ layer, and a barrier layer between the catalyst containing layer and the glucose sensing layer.
(2) by further crosslin~ing the analyte sensing layer to make it less permeable to the peroxidase enzyme. If the peroxidase catalyst is no longer a~le to permeate there will be no electrical contact between the electron relays and the peroxidase and no reduction current will be observed. Any protein crosslinking agent such as glutaraldehyde, cyanogen bromide, periodate, cyanuric chloride may be used to further crosslink the protein in the analyte sensing layer.
The following specific examples illustrate how the invention may be carried out but should not be considered as limiting the invention.
EXAM~LE 1 A piece of glassy carbon rod (10 mm long, 3 mm diameter, V
25 Vitreous Carbon, Atomergic Chemetals Corp., Farmington, N.Y.) was sealed in a glass tube with insulating epoxy resin (Quick Stick - GC Electronics, Roc~ford, Illinois). A copper wire was attached to the rear end of the rod with electrically conducting silver epoxy (Epo-tek H20E, Epoxy Technology Inc., Billerica, Mass.). The top end of the glass tube was polished with sand paper (grit 600) until a smooth surface was obtained, exposing a 3 mm disc of glassy carbon (the electrode surface). The electrode surface was pretreated by sequentially polishing with alumina powder (5.0, 1.0 and 0.3 micrometer particle size).
After each polishing step the electrode surface was rinsed with deionized water, son1cated for 3 minutes and dried under a s~ream of nitrogen.
Svnlhesis of the Osmium P~edox Polym2-, l"POs-EA"
Cis-bis(2,2'-bipyridine-N,N')dichloroosmium(II)[Lay,P.A.;
Sargeson, A.M.; Taube, H., Inorg. Synth., Vol. 24, 1986, pp. 291-306] (0.494 g, 0.864 mmol) and poly(4-vinylpyridine) (PvP, Polysciences- Worrington, PA, MW 50,000~ (0.430 g, 4.09 milliequivilant) were heated under nitrogen at reflux in 18 mL
ethylene glycol for 2 h. After cooling to room temperature, 30 mL Dimethyl formamide and lo S g 2-bromoethylamine hydrobromide (7.3 millimole) were added and the solution was stirred at 45C
overnight. The crude polymer was precipitated by pouring the solution into rapidly stirred acetone. The hygroscopic precipitate was collected, dissolved in H20, filtered, and precipitated as the PF6-salt by ad'dition of a solution of NH4PF6.
The dry PF6-salt (0.49 g) was then dissolved in 20 mL
acetonitrile, diluted with 50 mL H20 a-nd stirred over 5.2 g anion exchange beads (8io-Rad AG1-X4, chloride form) for 2 hours. This solution was filtered, and then evaporated in v~cuum to about 10 mL. Concentrated HCl was then added to make the solution pH 2, and the solution was dripped into rapidly stirred acetonitrile.
The precipitate was filtered and dried in a vacuum desiccator.
Preparation of t:he analyte (glucose) sensing layer (layer I) comprised preparing a solution containing 2 mg/ml osmium redox polymer (ios-EA), 0.12 mg/ml polyethylene glycol diglycidyl ether (Polysciences MW 400), and l mg/ml glucose oxidase (Sigma type X, St. Louis, Missouri, 128 units/mg) in a 5 mM HEPES buffer solution, pH 7.8. A one microliter droplet of the solution was applied on the electrode surface. The electrode was left in a vacuum desiccator at room temperature for 48 hours to set up.
2 ~ 5 ~
The glucose sensi~g layer ~as fu~ther crosslinked by dlppin~
the electrode in a 0.25% giutaraldehyde solution for 5 sec~nds, followed by rinsins with a phosphate buffer (p~ 7.2, 0.l molar ("M")) solution for 30 minutes. The purpose of this step is to avoid electrochemical contact between the electron relays and the peroxidase in the next layer.
The catalyst (POD) containing layer (layer II) was prepared by depositing 5 microliters of a POD (Sigma, type I, 85 units/mg) solution (100 mg/ml in a 0.1 ~ phosphate buffer pH 7.2 containing 5 mglml glutaraldehyde) on top of the barrier layer and was left for two hours to set up.
Electrochemical measurements were performed with a P-inceton Applied Research Model 273 potentiostat/galvanostat and recorded on a x-y-t chart recorder. Measurements were performed in a cell containing 5 ml of an electrolyte solution (0.1 M phosphate buffer, pH 7.2 and 0.1 M NaCl) using a three electrode configuration. The multilayer electrode was used as the working electrode, a saturated calomel electrode (SCE) was used as the reference electrode, and a platinum wire was used as the counter electrode. The potential of the working electrode was held at 400 mV with respect to the SCE electrode and the current flowing was measured as a function of time. Five microliters of a stock solution of glucose or of the interferant were added to the electrolyte solution and rapidly mixed. Stock solutions of the interferant compounds (ascorbate, urate, bilirubin and acetaminophen) were prepared fresh because such compounds tend to decompose when left standing.
Figure 4 shows the results of an experiment using a sensor as described above. In this experiment, glucose (final concentration 2.0 mM) and ascorbate (final concentration 0.1 mM) were separately added ~o a separate electrolyte solution and mixed rapidly. Figure 4(a) shows the currents measured in the 20~3~7 absence of hyd-osen pero~ide. Figure 4(b) shows the cur~ents .easured in the presence of hydrogen peroxide (0.1 mM).
Figure 5 shows the results of a similar experiment for different interferants. In this experiment, glucose (final concentration 2.0 mM) and acetaminophen (Tylenol) (final concentration o.1 mM) were separately added to a separate electrolyte solution and mixed rapidly. Figure 5(a) shows the currents in the absence of hydrogen peroxide. Figure 5(b) shows the currents measured in the presence of hydrogen peroxide (0.1 mM).
As shown in Figures 4 and 5, when H202 is present the false signal from the interferant is substantially reduced. The glucose signal is not affected by the catalyst containing layer that eliminates the interferants. Similar results are obtained when uric acid or bilirubin are used as the interferants instead of ascorbate or Tylenol. Similar results are also obtained when a mixture of the interferants is used. It is anticipated that similar results will be obtained from other interferants (such as Cysteine) that are oxidized by hydrogen peroxide in the presence of the catalyst (peroxidase) containing layer. The results shown ~
in Figures 4 and 5 are from experiments done with separate additions of glucose and the interferant. When a mixture containing glucose and one or more of the interferants is injected in the presence of H202 the current measured is equivalent to the measured for the injection of glucose alone.
This indicates that the interferant eliminating catalyst layer works as expected and prevents multiple interferants from reaching the electroactive layer.
It is anticip~te~that the procedure described in ~xample 1 is a preferred ~ ~ at will perform in a medium where hydrogen peroxide may-be added to the analyte solution from an external source. Examples of applications of this method include 2~n~
use ~or clinlcal analysis of samples (ex vivo), or analysis of sa~ples in indus~rial processes.
E 2~ E 2 An electrode was prepared as described in Example 1. On top of the catalyst containing layer a hydrogen peroxlde generating layer containing lactate oxidase (LOD) was immo~ilized by crosslinking it with glutaral~ehyde (Figure 3). This layer was prepared by depositing 5 microliters of a LOD (Finnsugar, Schaumburg, Illinois, 33 units/mg) solution (100 mg/ml in a 0.1 M
phosphate buffer pH 7.2 containing 5 mg/ml glutaraldehyde) on the POD layer. The sensor was then left for two hours to set up.
The experimental use of this electrode was similar to that described in Example 1 with the provision that lactate replaced hydrogen peroxide as the oxidant for the interferants. Thus, hydrogen peroxide was not added to the analyte solution. The results obtained with this electrode were similar to the results described in Example 1.
It is anticipated that the procedure described in Example 2 ~
is a preferred embodiment that will perform in a medium where it is undesirable to add hydrogen peroxide from an external source.
Examples of such applications are in vivo measurements, in use as disposable sensors for analysis of small amounts of analyte solution (for example, blood drops), or for use in industrial fermenters or reacto:r processes.
3 0 E~A~SP~ 3 An electrode was prepared as described in Example 1 for the electrode surface pretreatment and analyte sensing layer preparation. This layer was not further crosslinked with glutaraldehyde nor was it coated with a barrier layer. The ~I~S~5~
catalyst containing layer was coated directly on top of the analvte sensing layer by immobilizing POD on a hydrazide polymer mat-ix. Specifically, the catalys. containing layer was i~mobilized as follows: Solution (~) com?rised 5 mg/ml polyacrylamide hydrazide (~ater soluble, Si~ma #P9905) dissolved in water. Solution (B) comprised 2 mg Peroxidase (Si~ma, type VI, 260 units/mg) dissolved in 100 microliters 0.lM sodium bicarbonate solution. Sodium periodate (50 microliters of a 12 mg/ml solution) was added to solution (B) and that solu~ion was incubated in the dark at room temperature (20-25OC) for 2 hours.
After the incubation, 7.5 microliters from Solution (A) ~ere added to Solution (B) and 10 microliters of the mixture were applied on top of the glucose sensing layer. The electrode was left to set up for 2 hours and then used.
It is understood that the above-described method using Solutions (A) and (B) are interchangeable with similar procedures using glutaraldehyde (or similar compounds), and vice versa. The method using Solutions (A) and (~3) tends to be milder than other methods because it tends to destroy less of compounds it contacts.
The experimental use of this electrode was similar to that 2S described in Example 1 with the provision that a ~ore oxidative potential (500 mV vs. SCE instead of 400 mV vs. SC~) was applied to the working electrode. The results obtained with this electrode were similar to the results described in Example 1.
It is anticipated that the procedure described in Example 3 is a preferred embodiment for a sensor that only needs to perform for a short time period. This sensor tends to require a more oxidative potential for its use. The higher potential employed tends to decrease the useful life of the sensing element electrode. ~he advantage of this procedure is that it is simpler .'3~ 7, ~o apply since is involves one less step that the procedure outlined in Example 1 (i.e., this procedure does not entail application of an intermediate layer between the analyte sensing layer and the catalyst containing layer).
The interferant eliminating effect of this invention as described in all three examples is enhanced by the beneficial influence on the long term stability of the sensor by protecting the electroactive layer from deactivation _y oxidation products.
Specifically, elimination of the urate ion tends to have a beneficial effect on the long term stability of the sensors.
Further modifications and alternative e~bodiments of various aspects of the invention will be apparent to those skilled in the art in view of thls description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teachi-ng those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as the presently preferred embodiments. Elements and materials ~ay be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein or in the steps or in the sequence of steps of the methods described herein without departing from the spirit and scope of the invention as described in the following claims. Similarly, isomers and homologs of reactan s may be used and still come within the scope of the invention.
of interferants. U.S. patent 4,776,944 to Janata et al. appears to disclose a chemical selective sensor system which utilizes ad~ittance modul~tion to detect the presence of chemicals in a fluid. Commercial variations of the glucose sensors have also utilized filterinq membranes and electrostatic repulsion membranes to inhibit interferants f-om reaching the analyte sensing layer.
Despite the above described improvements, persons skilled in the art have not yet adequately solved the inaccuracy problems caused by interferants.
SUHXARY OF THE INVE~TION
lS A general object of this inventlon is to provide i~proved sensors and sensing methods wherein the effect of interferants is minimized or eliminated by oxidizing the interferants before they affect the accuracy of the assay. The problems in the prior art are solved by a novel sensor for detecting analyte concentration in the solution, comprising a sensing element with a sensing surface, and wherein the sensing surface is substantially surrounded or covered by a catalyst containing layer capable of oxidizing a plurality of interferants in the presence of an oxidant. In the examples, peroxidase was the catalyst and hydrogen peroxide was the oxidant. The sensing element comprises an electrode and an analyte sensing layer in electrical contact with the electrode. T~e analyte sensing layer comprises an enzyme which comprises an oxidoreductase. Examples of suitable oxidoreductases include glucose oxidase for glucose analysis, lactate oxidase for lactic acid analysis, etc.
One form of the ~ensor comprises the electrode described above, further comprising a catalyst containing layer immobilized on top of the first layer. The catalyst containing layer operates in the presence of an oxidant to oxidize the interferant 2~a~7 c~mpounds prior to those compounds reaching the sensing elemenl.
In thls manner the sensing element is protected fro~ the interfering influence of the interferants.
Since the catalyst containing laye~ may itself nega~ively affect the assay, it is advantageous to prevent the catalyst containing layer from interfering with the sensing elemen.. One method to prevent this interference entails adjusting the operating conditions such that the catalyst containing layer will no longer interfere. Alternately, a thin barrier layer between the analyte sensing layer and the catalyst containing layer may inhibit the catalyst contair,ing layer from permeating the analyte sensing layer and thus inhibiting the catalyst containing layer from coming into contact with the analyte sensing elements.
Still further, the analyte sensing layer may be crosslinked to make it less permeable to the catalyst containing layer, thus inhibi~ing the catalyst containing layer from coming into contact with the analyte sensing elements.
Since the oxidant itself may be undesirable in some circumstances, a methodology describing in sLtu production of the oxidant is provided. In this manner, the oxidant may be produced ~
by a separate enzyme in a separate layer, or by the same en2yme used in the analyte sensing layer. The oxidant producing enzyme may be mixed with the analyte sensing layer, with the catalyst containing layer, or may itself be a separate layer.
B~IEF DE8CRIPTION OF T~ DRAWING8 .
Figure l is a schematic view of an electrochemical glucose biosensor having a analyte (glucose) sensing layer on top of the electrode surface (layer I).
- Figure 2 is a schematic view of an electrochemical glucose biosensor with a catalyst containing layer that eliminates the 2~53~)~7 inte_ferants~ This device has a peroxidase catalyst containi~q layer covering the glucose sensin~ element (layer II).
Figure 3 is a schematic view of an electrochemical glucose biosensor with an catalyst containing layer that eliminates interferants and an oxidant (hydrogen peroxide) generating layer.
Ihis device has a layer of lactate oxidase (layer III) covering the catalyst containing layer. The purpose of layer III is to use lactic acid and oxygen to ~enerate the hydrogen peroxide needed in the catalyst containing layer.
Figure 4 shows the results of a measurement performed with an electrode of the type described in Example 1. The signals (current as a function of time) obtained upon additions of ascorbate (0.1 millimolar ("mM")) and glucose ~2 mM) are shown in "a" in the absence of hydrogen peroxide, and shown in "b" with hydrogen peroxide (O.1 mM) added.
Figure 5 shows the results of a measurement performed with an electrode of the type described in Example 1. The signals (current as a function of time) obtained upon additions of Tylenol (acetaminophen, 0.1 mM) and glucose (2 mM) are shown in "a" in the absence of hydrogen peroxide, and shown in "b" with hydrogen peroxide (0.1 mM) added.
Figure 6 is a schematic diagram of a multilayer electrode with an osmium based glucose sensing layer, and a barrier layer between the catalyst containing layer (interferant eliminating layer - i.e. immobilized peroxidase) and the analyte (glucose) sensing layer.
DE8CRIPT~ON OF T~E PREFERRED EMBODIMENT8 The device is an electrochemical analyte sensor composed of two or more layers of catalysts and electron relays (or 2 ~ 5 ~
~ediators) covering a solid electrode material. In the context of this applicatlon "analyte~ si~ply me2ns a substance being analyzed, detected, or measured in some manner (in the Examples, glucose is the analyte). Similarly, an "interferant" is a substance that interferes in some manner with any desired analyzation, detection, or measurement process.
The preferred electrode material is glassy carbon but it may be any other electrode material such as graphite, platinum, pal~adium, tin oxide, conducting organic salts, etc.. Typically, a wire electrically contacts with the electrode material.
Various layers of material are coated on the exposed surface of the electrode material. In some instances the electrode material itself is able to sense and detect the analyte but in most cases a special sensinq layer or a chemical modification has to be applied to the electrode material.
The analyte sensing layer (layer I in Figures 1, 2 or 3) contains the sensing elements for the particular analyte and is in close contact with the electrode material. For the purposes of this application it is intended that the phrase "analyte sensing layer" be interpreted broadly to include the necessary ~
sensing elements to detect and send a signal useful for analyzing the analyte. Usually this layer contains an enzyme that is in electrical contact with the electrode through electron relays incorporated in the layer or through diffusing redox mediators.
Alternatively, instead of free enzymes this layer may include cells or tissues which contain enzymes. Any known methodology may be used to bring the analyte sensing layer into electrochemical contact with the electrode. One such ~ethod is described in U.S. patent 4,758,232 to Davis et al.
Suitable analyte sensing layer enzymes are oxidoreductases such as dehydrogenases-or oxidases. Examples of suitable enzymes are glucose oxidase for glucose analysis, lactate oxidase for ~5~ 7 laclic acld analys~s, xanthine oxidase for xanthine analysis, c~olesterol oxidase for cholesterol analysis, pyruvate oxidase for pyruvic acid analysis, L-amino acid oxidases for L-ar~ino acid analysis, D-amino acid oxidases for D-amino acid analysis, alcohol oxidase for alcohol analysis, urease for urea analysis, glycollate oxidase for glycollate analysis, sarcosine oxidase for sarcosine analysis, and other similar enzymes. In the detailed description of the preferred embodiment, glucose oxidase (GOD) is used for the analysis of glucose.
Suitable mediators are electrochemically active compounds such as metal ions, conducting organic salts, quinones and their derivatives, organometallic complexes such as ferrocenes ar.d their derivatives, or polypyridine complexes of transition metals and their derivatives. The same type of compounds that will attach to an enzyme shell and make it electrically conductive will behave as electron relays. In the detailed description of the preferred embodiment a redox polymer based on a poly(vinylpyridine) complex of Osmium bis(bipyridine)chloride is the electron relay. This polymer is brought into close contact with the enzyme and the electrode surface using a crosslinking agent, poly(ethylene glycol) diglycidyl ether and forming an ~
epoxy redox gel.
The catalyst containing layer of the device contains the interferant eliminating elements. The basic component of this layer is a catalyst capable of mediating the following reaction:
H2O2 + AH2 catalY~t ~ 2H2O + A
In this general reaction AH2, the hydrogen donor, is a~
interfering compound and is oxidized by hydrogen peroxide to "A" -- that is, to a noninterfering compound that is no longer substantially electrochemically active. After oxidation the noninterfering compound "A" may diffuse to the analyte sensing 2 ~ n s ~
C~i`5 layer but does not interfer with the because compound "A" ls no longer electrochemically a~tive. The catalyst may ~e a natural enzyme of the peroxidase type such as horseradish peroxidase or a synthetic or semisynthetic catalyst such as some model compound for peroxidase (for example, Iron (III) porphyrins). In the detailed description of the preferred embodiment horseradish peroxidase (PO3) is used as the catalyst.
POD is an enzyme that works weil as a catalyst for the above equation. The POD enzy~e has a low specificity for the hydrogen donor (AX2). A large number of compounds including phenols, aminophenols, diamines, indophenols, leucodyes, ascorbate and amino acids are active as such. More importantly, interferants present in physiological fluids such as ascorbate, urate, acetaminophen, bilirubin, or cysteine are rapidly oxidized by hydrogen peroxide in the presence of POD. Thus a POD containing layer will eliminate these compounds from the electrode vicinity when exposed to H2O2. It is anticipated that any other interfering compound oxidized by hydrogen peroxide in the presence of a suitable catalyst will be promptly removed using this catalyst.
Optimally, the catalyst should cover the analyte sensing layer in such a way that the interferants will come in contact with the catalyst before reaching the analyte sensing layer (see Figure 2). The catalyst may be positioned to cover the analyte sensing layer in this manner using two methods:
(l) using a soluble catalyst contained near the first layer by a dialysis membrane, or (2) using an insolubilized catalyst that coats the analyte sensing layer.
2 ~ 1.5 7 In ~ethod (2), the ca~alyst may be ~ttached to an in~oluble mat~ix or it may be crosslinked with a crosslinking agent formin~
a gel-like structure that is no longer soluble. In the case of the peroxidase type enzymes, protein crosslinking agents such as bifunctional or polyfunctional reagents may be used.
BifunctLonal reagents are used to insolubilize enzymes by intermolecular crosslinking. Crosslinking agents suitable for immobilizing enzymes include glutaraldehyde, cyanogen bromide, periodate, or cyanuric chloride. In the detailed description of the preferred embodiment, horseradish peroxidase (POD) is crosslinked by two alternative methods:
tl) using glutaraldehyde as a crosslinking agent, or (2) oxidation of the oligosaccharide groups in the POD
glycoenzyme with NaIO4, followed by coupling of the - aldehydes formed to hydrazide groups in a polyacrylamide matrix to form hydrazones.
When the interfering compound reaches the catalyst containing layer (layer II) it is oxidized by hydrogen peroxide, thus preventing it from reaching the analyte sensing layer (layer ~
I) and its subsequent electrochemical detection. Hydrogen peroxide is present in one of two ways:
(1) it may be added to the assayed solution, or (2) it may be produced in situ by an enzyme of the oxidase class according to the following equation:
substrate + 2 oxldase ~ oxidized substrate + H2O2 One or more enzymes capable of producing hydrogen peroxide may be included in the H2O2 generating layer as long as appropriate 2~50~57 corresponding substrates are present in the analyzed sample.
Exa~ples of suitable enzymes are glucose oxidase with glucose as the substrate, lactate oxidase with lactic acid as the substrate, xanthine oxidase with xanthine as the substrate, pyruvate oxidase with pyruvate as the substrate, amino acid oxidase with amino acids as the substrates, choline oxidase with choline as the substrate, alcohol oxidase with alcohol as the substrate, ascorbate oxidase with ascorbate as the substrate, urate oxidase with urate as the substrate, aldehyde oxldase with aldehyde as the substrate, sarcosine oxidase with sarcosine as the substrate, etc.
The hydrogen peroxide generating enzyme may be the same enzyme that is being used in the analyte sensing layer as the analyzing enzvme. For example, in the case of a glucose sensor, part of the glucose oxidase will mediate the oxidation of glucose by the electrode through the electron relays, thus providing for the analysis of glucose. The remaining glucose oxidase will mediate the oxidation of glucose by oxygen, thus generating hydrogen peroxide that will be subsequently used in the catalyst containing layer for elimination of the interferants.
This hydrogen peroxide generating enzyme will be contained in a third layer (Figure 3, layer III) and/or it can be mixed together with the catalyst containing layer, or in the analyte sensing layer. The hydrogen peroxide generating enzyme is preferrabIy located near the interferant eliminating catalyst.
This enzyme also may be used as a soluble enzyme contained by a - membrane or as an insoluble enzyme attached to the previous layers. In the detailed description of the preferred embodiment (Example 3) lactate oxidase is used as the hydrogen peroxide generating enzyme according to the following equation:
lactate lactate + 2 oxida~e > pyrUvate + ~{22 2~ 357 In this exa~ple lactate oxidase (LOD) is iN~o~ilized on top of ~he peroxidase layer ~sing glutaraldehyde as the crosslinking reagent.
The multilayer electrodes prepared in this way may be used for all the different kinds of electrochemical sensing methods.
Amperometric, potentiometric, conductimetric or impidi~etric devices as well as i~munoelectrodes can benefit from the use of the interferant elimlnating layers. For the purpose of demonstration the electrodes are used as an amperometric sensin~
device.
Mea~urements are performed in a medium containing an electrolyte and using a three electrode configuration: the multilayer electrode is used as the working electrode, saturated calomel electrode (SCE) or Ag/AgCl is used as a reference electrode, and a metal wire is used as the counter elec.rode.
Alternatively a two electrode configuration may be used (for instance, with Ag/AgCl as both the reference and counter electrodes).
In the detailed description of the preferred embodiment the -multilayer electrode is used as the working electrode, a saturated calomel electrode (SCE) is used as the reference electrode, and a platinum wire is used as the counter electrode in a glass cell containing an electrolyte.
The cell may contain the analyzed sample or this sample may be injected into the cell at a later time. An electrochemical potential is applied to the working electrode with respect to the reference electrode and the current flowing is measured as a function of time. The choice of the electrochemical potential is dependent upon the mediator or electron relay used, as well as the enzyme properties.
The measured current is generally proportional to the concentration of the species being oxidized. When the (interferant eli~inating) catalyst containing layer is no.
active, both the analyte and the interfering species are being s oxidized. Thus the measured current is proportional to both concentrations and the readlng is a false reading. When the catalyst containing layer is active, the interferants are enzymatically oxidized in the catalyst containing layer and do not reach the analyte sensing layer. In the latter case the current being measured is proportional only to the analyte concentration.
Under certain operating conditions the peroxidase enzyme (or the alternative catalyst) may mediate the electrochemical reduction of hydrogen peroxide. This electrochemical reaction is also mediated by the same electron relays that are used in the analyte sensinq element (layer I). This process will result in a reduction current superimposed cn the oxidation current of the analyte and the net current will no longer be proportional to the analyte concentration. This is an undesired situation and it may be prevented in one of the two methods:
(1) by making the potential of the working electrode more oxidative in such a way that the reduction process will no longer proceed; while the oxidations will still proceed.
(2) by preventing electrical contact between the catalyst (peroxidase) and the electron relays.
Preventing electrical contact as in method (2) above may be achieved by either:
(1) applying a thin electrically insulating barrier layer between the analyte sensing layer and the catalyst containing layer. This barrier may be cast from a variety of film or 2 ~ 1 .5 ~1 me~brane for~ing polymers such as cellulose acetate or other cellulose derivatives, polycarbonates, or perfluorinated r~embranes, etc. Figure 6 shows a schematic diagram of a multilayer electrode with an osmium based glucose sensin~ layer, and a barrier layer between the catalyst containing layer and the glucose sensing layer.
(2) by further crosslin~ing the analyte sensing layer to make it less permeable to the peroxidase enzyme. If the peroxidase catalyst is no longer a~le to permeate there will be no electrical contact between the electron relays and the peroxidase and no reduction current will be observed. Any protein crosslinking agent such as glutaraldehyde, cyanogen bromide, periodate, cyanuric chloride may be used to further crosslink the protein in the analyte sensing layer.
The following specific examples illustrate how the invention may be carried out but should not be considered as limiting the invention.
EXAM~LE 1 A piece of glassy carbon rod (10 mm long, 3 mm diameter, V
25 Vitreous Carbon, Atomergic Chemetals Corp., Farmington, N.Y.) was sealed in a glass tube with insulating epoxy resin (Quick Stick - GC Electronics, Roc~ford, Illinois). A copper wire was attached to the rear end of the rod with electrically conducting silver epoxy (Epo-tek H20E, Epoxy Technology Inc., Billerica, Mass.). The top end of the glass tube was polished with sand paper (grit 600) until a smooth surface was obtained, exposing a 3 mm disc of glassy carbon (the electrode surface). The electrode surface was pretreated by sequentially polishing with alumina powder (5.0, 1.0 and 0.3 micrometer particle size).
After each polishing step the electrode surface was rinsed with deionized water, son1cated for 3 minutes and dried under a s~ream of nitrogen.
Svnlhesis of the Osmium P~edox Polym2-, l"POs-EA"
Cis-bis(2,2'-bipyridine-N,N')dichloroosmium(II)[Lay,P.A.;
Sargeson, A.M.; Taube, H., Inorg. Synth., Vol. 24, 1986, pp. 291-306] (0.494 g, 0.864 mmol) and poly(4-vinylpyridine) (PvP, Polysciences- Worrington, PA, MW 50,000~ (0.430 g, 4.09 milliequivilant) were heated under nitrogen at reflux in 18 mL
ethylene glycol for 2 h. After cooling to room temperature, 30 mL Dimethyl formamide and lo S g 2-bromoethylamine hydrobromide (7.3 millimole) were added and the solution was stirred at 45C
overnight. The crude polymer was precipitated by pouring the solution into rapidly stirred acetone. The hygroscopic precipitate was collected, dissolved in H20, filtered, and precipitated as the PF6-salt by ad'dition of a solution of NH4PF6.
The dry PF6-salt (0.49 g) was then dissolved in 20 mL
acetonitrile, diluted with 50 mL H20 a-nd stirred over 5.2 g anion exchange beads (8io-Rad AG1-X4, chloride form) for 2 hours. This solution was filtered, and then evaporated in v~cuum to about 10 mL. Concentrated HCl was then added to make the solution pH 2, and the solution was dripped into rapidly stirred acetonitrile.
The precipitate was filtered and dried in a vacuum desiccator.
Preparation of t:he analyte (glucose) sensing layer (layer I) comprised preparing a solution containing 2 mg/ml osmium redox polymer (ios-EA), 0.12 mg/ml polyethylene glycol diglycidyl ether (Polysciences MW 400), and l mg/ml glucose oxidase (Sigma type X, St. Louis, Missouri, 128 units/mg) in a 5 mM HEPES buffer solution, pH 7.8. A one microliter droplet of the solution was applied on the electrode surface. The electrode was left in a vacuum desiccator at room temperature for 48 hours to set up.
2 ~ 5 ~
The glucose sensi~g layer ~as fu~ther crosslinked by dlppin~
the electrode in a 0.25% giutaraldehyde solution for 5 sec~nds, followed by rinsins with a phosphate buffer (p~ 7.2, 0.l molar ("M")) solution for 30 minutes. The purpose of this step is to avoid electrochemical contact between the electron relays and the peroxidase in the next layer.
The catalyst (POD) containing layer (layer II) was prepared by depositing 5 microliters of a POD (Sigma, type I, 85 units/mg) solution (100 mg/ml in a 0.1 ~ phosphate buffer pH 7.2 containing 5 mglml glutaraldehyde) on top of the barrier layer and was left for two hours to set up.
Electrochemical measurements were performed with a P-inceton Applied Research Model 273 potentiostat/galvanostat and recorded on a x-y-t chart recorder. Measurements were performed in a cell containing 5 ml of an electrolyte solution (0.1 M phosphate buffer, pH 7.2 and 0.1 M NaCl) using a three electrode configuration. The multilayer electrode was used as the working electrode, a saturated calomel electrode (SCE) was used as the reference electrode, and a platinum wire was used as the counter electrode. The potential of the working electrode was held at 400 mV with respect to the SCE electrode and the current flowing was measured as a function of time. Five microliters of a stock solution of glucose or of the interferant were added to the electrolyte solution and rapidly mixed. Stock solutions of the interferant compounds (ascorbate, urate, bilirubin and acetaminophen) were prepared fresh because such compounds tend to decompose when left standing.
Figure 4 shows the results of an experiment using a sensor as described above. In this experiment, glucose (final concentration 2.0 mM) and ascorbate (final concentration 0.1 mM) were separately added ~o a separate electrolyte solution and mixed rapidly. Figure 4(a) shows the currents measured in the 20~3~7 absence of hyd-osen pero~ide. Figure 4(b) shows the cur~ents .easured in the presence of hydrogen peroxide (0.1 mM).
Figure 5 shows the results of a similar experiment for different interferants. In this experiment, glucose (final concentration 2.0 mM) and acetaminophen (Tylenol) (final concentration o.1 mM) were separately added to a separate electrolyte solution and mixed rapidly. Figure 5(a) shows the currents in the absence of hydrogen peroxide. Figure 5(b) shows the currents measured in the presence of hydrogen peroxide (0.1 mM).
As shown in Figures 4 and 5, when H202 is present the false signal from the interferant is substantially reduced. The glucose signal is not affected by the catalyst containing layer that eliminates the interferants. Similar results are obtained when uric acid or bilirubin are used as the interferants instead of ascorbate or Tylenol. Similar results are also obtained when a mixture of the interferants is used. It is anticipated that similar results will be obtained from other interferants (such as Cysteine) that are oxidized by hydrogen peroxide in the presence of the catalyst (peroxidase) containing layer. The results shown ~
in Figures 4 and 5 are from experiments done with separate additions of glucose and the interferant. When a mixture containing glucose and one or more of the interferants is injected in the presence of H202 the current measured is equivalent to the measured for the injection of glucose alone.
This indicates that the interferant eliminating catalyst layer works as expected and prevents multiple interferants from reaching the electroactive layer.
It is anticip~te~that the procedure described in ~xample 1 is a preferred ~ ~ at will perform in a medium where hydrogen peroxide may-be added to the analyte solution from an external source. Examples of applications of this method include 2~n~
use ~or clinlcal analysis of samples (ex vivo), or analysis of sa~ples in indus~rial processes.
E 2~ E 2 An electrode was prepared as described in Example 1. On top of the catalyst containing layer a hydrogen peroxlde generating layer containing lactate oxidase (LOD) was immo~ilized by crosslinking it with glutaral~ehyde (Figure 3). This layer was prepared by depositing 5 microliters of a LOD (Finnsugar, Schaumburg, Illinois, 33 units/mg) solution (100 mg/ml in a 0.1 M
phosphate buffer pH 7.2 containing 5 mg/ml glutaraldehyde) on the POD layer. The sensor was then left for two hours to set up.
The experimental use of this electrode was similar to that described in Example 1 with the provision that lactate replaced hydrogen peroxide as the oxidant for the interferants. Thus, hydrogen peroxide was not added to the analyte solution. The results obtained with this electrode were similar to the results described in Example 1.
It is anticipated that the procedure described in Example 2 ~
is a preferred embodiment that will perform in a medium where it is undesirable to add hydrogen peroxide from an external source.
Examples of such applications are in vivo measurements, in use as disposable sensors for analysis of small amounts of analyte solution (for example, blood drops), or for use in industrial fermenters or reacto:r processes.
3 0 E~A~SP~ 3 An electrode was prepared as described in Example 1 for the electrode surface pretreatment and analyte sensing layer preparation. This layer was not further crosslinked with glutaraldehyde nor was it coated with a barrier layer. The ~I~S~5~
catalyst containing layer was coated directly on top of the analvte sensing layer by immobilizing POD on a hydrazide polymer mat-ix. Specifically, the catalys. containing layer was i~mobilized as follows: Solution (~) com?rised 5 mg/ml polyacrylamide hydrazide (~ater soluble, Si~ma #P9905) dissolved in water. Solution (B) comprised 2 mg Peroxidase (Si~ma, type VI, 260 units/mg) dissolved in 100 microliters 0.lM sodium bicarbonate solution. Sodium periodate (50 microliters of a 12 mg/ml solution) was added to solution (B) and that solu~ion was incubated in the dark at room temperature (20-25OC) for 2 hours.
After the incubation, 7.5 microliters from Solution (A) ~ere added to Solution (B) and 10 microliters of the mixture were applied on top of the glucose sensing layer. The electrode was left to set up for 2 hours and then used.
It is understood that the above-described method using Solutions (A) and (B) are interchangeable with similar procedures using glutaraldehyde (or similar compounds), and vice versa. The method using Solutions (A) and (~3) tends to be milder than other methods because it tends to destroy less of compounds it contacts.
The experimental use of this electrode was similar to that 2S described in Example 1 with the provision that a ~ore oxidative potential (500 mV vs. SCE instead of 400 mV vs. SC~) was applied to the working electrode. The results obtained with this electrode were similar to the results described in Example 1.
It is anticipated that the procedure described in Example 3 is a preferred embodiment for a sensor that only needs to perform for a short time period. This sensor tends to require a more oxidative potential for its use. The higher potential employed tends to decrease the useful life of the sensing element electrode. ~he advantage of this procedure is that it is simpler .'3~ 7, ~o apply since is involves one less step that the procedure outlined in Example 1 (i.e., this procedure does not entail application of an intermediate layer between the analyte sensing layer and the catalyst containing layer).
The interferant eliminating effect of this invention as described in all three examples is enhanced by the beneficial influence on the long term stability of the sensor by protecting the electroactive layer from deactivation _y oxidation products.
Specifically, elimination of the urate ion tends to have a beneficial effect on the long term stability of the sensors.
Further modifications and alternative e~bodiments of various aspects of the invention will be apparent to those skilled in the art in view of thls description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teachi-ng those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as the presently preferred embodiments. Elements and materials ~ay be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein or in the steps or in the sequence of steps of the methods described herein without departing from the spirit and scope of the invention as described in the following claims. Similarly, isomers and homologs of reactan s may be used and still come within the scope of the invention.
Claims (10)
1. A biosensor comprising:
an electrode;
a sensing surface containing an oxidoreductase in electrical contact with said electrode;
an interferant-eliminating surface containing a catalyst not in electrical contact with said electrode, said catalyst capable of catalyzing the oxidation of a plurality of interferants in the presence of an oxidant.
an electrode;
a sensing surface containing an oxidoreductase in electrical contact with said electrode;
an interferant-eliminating surface containing a catalyst not in electrical contact with said electrode, said catalyst capable of catalyzing the oxidation of a plurality of interferants in the presence of an oxidant.
2. The biosensor of claim 1, wherein said catalyst is kept from electrical contact with said electrode by means of a mechanical barrier.
3. The biosensor of claim 1, wherein relative redox potentials at the sensing surface and at the interferant-eliminating surface are such that electrical contact of the oxidoreductase with the electrode is achieved but electrical contact of the catalyst with the electrode is prevented at the useful operating voltage range.
4. The biosensor of claim 2, wherein said mechanical barrier comprises an insulating barrier layer between the sensing surface and the interferant-eliminating surface.
5. The biosensor of claim 2, wherein said mechanical barrier comprises a crosslinked polymer in the sensing surface.
6. The biosensor of any of claims 1 to 5, wherein said oxidoreductase is glucose oxidase, lactate oxidase, xanthine oxidase, cholesterol oxidase, pyruvate oxidase, L-amino acid oxidase, D-amino acid oxidase, alcohol oxidase, urate oxidase, aldehyde oxidase, glycolate oxidase, or sarcosine oxidase.
7. The biosensor of any of claims 1 to 6, wherein said catalyst comprises horseradish peroxidase, cytochrome c peroxidase, chloroperoxidase, lactoperoxidase, thyroid peroxidase, Japanese radish peroxidase a, Japanese radish peroxidase c, myeloperoxidase, NADH peroxidase, turnip peroxidase A1, turnip peroxidase A2, turnip peroxidase B, turnip peroxidase D, glutathione peroxidase, or an iron (III) porphyrin.
8. The biosensor of claim 6, wherein said oxidoreductase is glucose oxidase.
9. The biosensor of claim 7, wherein said catalyst contains horseradish peroxidase.
10. A process for analyzing analyte in the presence of a plurality of interferants in a test sample comprising the steps of:
adding an oxidant to a sample;
immersing the sensor of any of claims 1 to 9 into the sample such that interferants are substantially oxidized by the interferant-eliminating surface; and detecting the analyte by the sensing surface.
adding an oxidant to a sample;
immersing the sensor of any of claims 1 to 9 into the sample such that interferants are substantially oxidized by the interferant-eliminating surface; and detecting the analyte by the sensing surface.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66405491A | 1991-03-04 | 1991-03-04 | |
| US664,054 | 1991-03-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2050057A1 true CA2050057A1 (en) | 1992-09-05 |
Family
ID=24664326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002050057A Abandoned CA2050057A1 (en) | 1991-03-04 | 1991-08-27 | Interferant eliminating biosensors |
Country Status (3)
| Country | Link |
|---|---|
| US (5) | US5356786A (en) |
| JP (1) | JPH04278450A (en) |
| CA (1) | CA2050057A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0652436A2 (en) * | 1993-11-04 | 1995-05-10 | Lg Electronics Inc. | Bio-sensor for measuring alcohol concentration, method for manufacturing the bio-sensor and drunkometer using the same |
Families Citing this family (534)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5593852A (en) * | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
| JPH04278450A (en) | 1991-03-04 | 1992-10-05 | Adam Heller | Biosensor and method for analyzing subject |
| GB9215973D0 (en) * | 1992-07-28 | 1992-09-09 | Univ Manchester | Sensor devices |
| US5956501A (en) * | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
| US5824473A (en) * | 1993-12-10 | 1998-10-20 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| US6071699A (en) | 1996-06-07 | 2000-06-06 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| US5620850A (en) | 1994-09-26 | 1997-04-15 | President And Fellows Of Harvard College | Molecular recognition at surfaces derivatized with self-assembled monolayers |
| US6329139B1 (en) | 1995-04-25 | 2001-12-11 | Discovery Partners International | Automated sorting system for matrices with memory |
| US5611900A (en) * | 1995-07-20 | 1997-03-18 | Michigan State University | Microbiosensor used in-situ |
| US5755953A (en) * | 1995-12-18 | 1998-05-26 | Abbott Laboratories | Interference free biosensor |
| US5830341A (en) * | 1996-01-23 | 1998-11-03 | Gilmartin; Markas A. T. | Electrodes and metallo isoindole ringed compounds |
| US5795453A (en) * | 1996-01-23 | 1998-08-18 | Gilmartin; Markas A. T. | Electrodes and metallo isoindole ringed compounds |
| US7393645B2 (en) * | 1996-11-05 | 2008-07-01 | Clinical Micro Sensors, Inc. | Compositions for the electronic detection of analytes utilizing monolayers |
| US7160678B1 (en) | 1996-11-05 | 2007-01-09 | Clinical Micro Sensors, Inc. | Compositions for the electronic detection of analytes utilizing monolayers |
| US7381525B1 (en) | 1997-03-07 | 2008-06-03 | Clinical Micro Sensors, Inc. | AC/DC voltage apparatus for detection of nucleic acids |
| US7014992B1 (en) | 1996-11-05 | 2006-03-21 | Clinical Micro Sensors, Inc. | Conductive oligomers attached to electrodes and nucleoside analogs |
| US7045285B1 (en) * | 1996-11-05 | 2006-05-16 | Clinical Micro Sensors, Inc. | Electronic transfer moieties attached to peptide nucleic acids |
| DE69809391T2 (en) | 1997-02-06 | 2003-07-10 | Therasense Inc | SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION |
| US6001067A (en) * | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
| US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
| US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
| US7192450B2 (en) | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
| US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
| US6741877B1 (en) | 1997-03-04 | 2004-05-25 | Dexcom, Inc. | Device and method for determining analyte levels |
| JP4124830B2 (en) | 1997-06-12 | 2008-07-23 | クリニカル・マイクロ・センサーズ・インコーポレイテッド | Electrical method for analyte detection |
| US6013459A (en) | 1997-06-12 | 2000-01-11 | Clinical Micro Sensors, Inc. | Detection of analytes using reorganization energy |
| US5922183A (en) * | 1997-06-23 | 1999-07-13 | Eic Laboratories, Inc. | Metal oxide matrix biosensors |
| US6030827A (en) * | 1998-01-23 | 2000-02-29 | I-Stat Corporation | Microfabricated aperture-based sensor |
| CA2319170A1 (en) | 1998-01-27 | 1999-07-29 | Clinical Micro Sensors, Inc. | Amplification of nucleic acids with electronic detection |
| US6686150B1 (en) | 1998-01-27 | 2004-02-03 | Clinical Micro Sensors, Inc. | Amplification of nucleic acids with electronic detection |
| US6479015B1 (en) | 1998-03-03 | 2002-11-12 | Pepex Biomedical, Llc | Apparatus for monitoring a level of a chemical species in a body fluid |
| US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
| US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
| US6085576A (en) * | 1998-03-20 | 2000-07-11 | Cyrano Sciences, Inc. | Handheld sensing apparatus |
| US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| ATE407220T1 (en) | 1998-05-06 | 2008-09-15 | Clinical Micro Sensors Inc | ELECTRONIC METHOD FOR DETECTING ANALYTES USING SINGLE LAYERS |
| US6294281B1 (en) * | 1998-06-17 | 2001-09-25 | Therasense, Inc. | Biological fuel cell and method |
| US7087148B1 (en) | 1998-06-23 | 2006-08-08 | Clinical Micro Sensors, Inc. | Binding acceleration techniques for the detection of analytes |
| US6761816B1 (en) | 1998-06-23 | 2004-07-13 | Clinical Micro Systems, Inc. | Printed circuit boards with monolayers and capture ligands |
| US6638716B2 (en) | 1998-08-24 | 2003-10-28 | Therasense, Inc. | Rapid amperometric verification of PCR amplification of DNA |
| US6251260B1 (en) | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
| US6281006B1 (en) | 1998-08-24 | 2001-08-28 | Therasense, Inc. | Electrochemical affinity assay |
| US6740518B1 (en) | 1998-09-17 | 2004-05-25 | Clinical Micro Sensors, Inc. | Signal detection techniques for the detection of analytes |
| WO2000019887A1 (en) * | 1998-10-08 | 2000-04-13 | Minimed Inc. | Telemetered characteristic monitor system |
| US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| AU1241000A (en) | 1998-10-27 | 2000-05-15 | Clinical Micro Sensors, Inc. | Detection of target analytes using particles and electrodes |
| US7766873B2 (en) | 1998-10-29 | 2010-08-03 | Medtronic Minimed, Inc. | Method and apparatus for detecting occlusions in an ambulatory infusion pump |
| US7621893B2 (en) | 1998-10-29 | 2009-11-24 | Medtronic Minimed, Inc. | Methods and apparatuses for detecting occlusions in an ambulatory infusion pump |
| US6128519A (en) | 1998-12-16 | 2000-10-03 | Pepex Biomedical, Llc | System and method for measuring a bioanalyte such as lactate |
| US6833267B1 (en) | 1998-12-30 | 2004-12-21 | Clinical Micro Sensors, Inc. | Tissue collection devices containing biosensors |
| US6565738B1 (en) * | 1999-01-28 | 2003-05-20 | Abbott Laboratories | Diagnostic test for the measurement of analyte in abiological fluid |
| US7312087B2 (en) | 2000-01-11 | 2007-12-25 | Clinical Micro Sensors, Inc. | Devices and methods for biochip multiplexing |
| US20020177135A1 (en) | 1999-07-27 | 2002-11-28 | Doung Hau H. | Devices and methods for biochip multiplexing |
| US7806886B2 (en) | 1999-06-03 | 2010-10-05 | Medtronic Minimed, Inc. | Apparatus and method for controlling insulin infusion with state variable feedback |
| JP4801301B2 (en) | 1999-06-18 | 2011-10-26 | アボット ダイアベティス ケア インコーポレイテッド | In vivo analyte sensor with limited mass transfer |
| US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
| US8268143B2 (en) * | 1999-11-15 | 2012-09-18 | Abbott Diabetes Care Inc. | Oxygen-effect free analyte sensor |
| US8444834B2 (en) | 1999-11-15 | 2013-05-21 | Abbott Diabetes Care Inc. | Redox polymers for use in analyte monitoring |
| AU1607801A (en) * | 1999-11-15 | 2001-05-30 | Therasense, Inc. | Transition metal complexes with bidentate ligand having an imidazole ring |
| KR100360774B1 (en) | 1999-12-27 | 2002-11-13 | 한국전자통신연구원 | Enzyme electrode sensor and manufacturing method thereof |
| US20030060765A1 (en) * | 2000-02-16 | 2003-03-27 | Arthur Campbell | Infusion device menu structure and method of using the same |
| JP4382265B2 (en) * | 2000-07-12 | 2009-12-09 | 日本電気株式会社 | Method and apparatus for forming silicon oxide film |
| US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
| US8070934B2 (en) | 2001-05-11 | 2011-12-06 | Abbott Diabetes Care Inc. | Transition metal complexes with (pyridyl)imidazole ligands |
| US8226814B2 (en) * | 2001-05-11 | 2012-07-24 | Abbott Diabetes Care Inc. | Transition metal complexes with pyridyl-imidazole ligands |
| US6676816B2 (en) * | 2001-05-11 | 2004-01-13 | Therasense, Inc. | Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes |
| US6932894B2 (en) * | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
| US7005273B2 (en) * | 2001-05-16 | 2006-02-28 | Therasense, Inc. | Method for the determination of glycated hemoglobin |
| US20030136673A1 (en) * | 2001-05-31 | 2003-07-24 | Denis Pilloud | Amperometric sensors using synthetic substrates based on modeled active-site chemistry |
| US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
| US20030032874A1 (en) | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
| US6827702B2 (en) | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
| US7052591B2 (en) * | 2001-09-21 | 2006-05-30 | Therasense, Inc. | Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking |
| US6952604B2 (en) | 2001-12-21 | 2005-10-04 | Becton, Dickinson And Company | Minimally-invasive system and method for monitoring analyte levels |
| US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
| US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US7368190B2 (en) * | 2002-05-02 | 2008-05-06 | Abbott Diabetes Care Inc. | Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods |
| US7226978B2 (en) | 2002-05-22 | 2007-06-05 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
| US8512276B2 (en) * | 2002-07-24 | 2013-08-20 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
| US7278983B2 (en) | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
| US20040068230A1 (en) | 2002-07-24 | 2004-04-08 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
| EP2322798A1 (en) | 2002-10-09 | 2011-05-18 | Abbott Diabetes Care Inc. | Device and method for delivering medical fluids using a shape memory alloy |
| US7727181B2 (en) | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
| US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
| US7501053B2 (en) * | 2002-10-23 | 2009-03-10 | Abbott Laboratories | Biosensor having improved hematocrit and oxygen biases |
| AU2003291250A1 (en) * | 2002-11-05 | 2004-06-07 | Therasense, Inc. | Assay device, system and method |
| US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
| US7638228B2 (en) * | 2002-11-27 | 2009-12-29 | Saint Louis University | Enzyme immobilization for use in biofuel cells and sensors |
| US20040122353A1 (en) | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
| US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
| US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
| US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
| US7679407B2 (en) | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
| US7875293B2 (en) | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
| US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
| US7651596B2 (en) | 2005-04-08 | 2010-01-26 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
| US7467003B2 (en) | 2003-12-05 | 2008-12-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US7366556B2 (en) | 2003-12-05 | 2008-04-29 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US7460898B2 (en) * | 2003-12-05 | 2008-12-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US7424318B2 (en) | 2003-12-05 | 2008-09-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US7761130B2 (en) | 2003-07-25 | 2010-07-20 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US8282549B2 (en) | 2003-12-09 | 2012-10-09 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
| JP4708342B2 (en) | 2003-07-25 | 2011-06-22 | デックスコム・インコーポレーテッド | Oxygen augmentation membrane system for use in implantable devices |
| US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
| US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
| US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8676287B2 (en) | 2003-08-01 | 2014-03-18 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US8060173B2 (en) | 2003-08-01 | 2011-11-15 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
| US8233959B2 (en) | 2003-08-22 | 2012-07-31 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
| US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
| US8007656B2 (en) | 2003-10-24 | 2011-08-30 | Bayer Healthcare Llc | Enzymatic electrochemical biosensor |
| SG135191A1 (en) * | 2003-10-29 | 2007-09-28 | Agency Science Tech & Res | Biosensor |
| US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
| USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
| US8859151B2 (en) * | 2003-11-05 | 2014-10-14 | St. Louis University | Immobilized enzymes in biocathodes |
| US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
| WO2005051170A2 (en) | 2003-11-19 | 2005-06-09 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
| US8532730B2 (en) | 2006-10-04 | 2013-09-10 | Dexcom, Inc. | Analyte sensor |
| US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
| DE602004029092D1 (en) | 2003-12-05 | 2010-10-21 | Dexcom Inc | CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTIC SENSOR |
| US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| ES2646312T3 (en) * | 2003-12-08 | 2017-12-13 | Dexcom, Inc. | Systems and methods to improve electromechanical analyte sensors |
| EP1713926B1 (en) | 2004-02-06 | 2012-08-01 | Bayer HealthCare, LLC | Oxidizable species as an internal reference for biosensors and method of use |
| US8165651B2 (en) * | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
| US7699964B2 (en) | 2004-02-09 | 2010-04-20 | Abbott Diabetes Care Inc. | Membrane suitable for use in an analyte sensor, analyte sensor, and associated method |
| US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
| US7709134B2 (en) * | 2004-03-15 | 2010-05-04 | St. Louis University | Microfluidic biofuel cell |
| US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
| US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US20060010098A1 (en) | 2004-06-04 | 2006-01-12 | Goodnow Timothy T | Diabetes care host-client architecture and data management system |
| US20070100222A1 (en) * | 2004-06-14 | 2007-05-03 | Metronic Minimed, Inc. | Analyte sensing apparatus for hospital use |
| US7946984B2 (en) * | 2004-07-13 | 2011-05-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
| WO2006127694A2 (en) | 2004-07-13 | 2006-11-30 | Dexcom, Inc. | Analyte sensor |
| US8886272B2 (en) | 2004-07-13 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
| US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
| US20060016700A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7344500B2 (en) | 2004-07-27 | 2008-03-18 | Medtronic Minimed, Inc. | Sensing system with auxiliary display |
| US7303543B1 (en) | 2004-12-03 | 2007-12-04 | Medtronic Minimed, Inc. | Medication infusion set |
| US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
| US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
| US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
| US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
| US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
| US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
| US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
| US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
| US20090105569A1 (en) | 2006-04-28 | 2009-04-23 | Abbott Diabetes Care, Inc. | Introducer Assembly and Methods of Use |
| US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
| US7731657B2 (en) | 2005-08-30 | 2010-06-08 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
| US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
| US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
| US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
| US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
| US7704229B2 (en) | 2005-02-03 | 2010-04-27 | Medtronic Minimed, Inc. | Insertion device |
| US20060189926A1 (en) * | 2005-02-14 | 2006-08-24 | Hall W D | Apparatus and methods for analyzing body fluid samples |
| US7722537B2 (en) * | 2005-02-14 | 2010-05-25 | Optiscan Biomedical Corp. | Method and apparatus for detection of multiple analytes |
| WO2006102412A2 (en) | 2005-03-21 | 2006-09-28 | Abbott Diabetes Care, Inc. | Method and system for providing integrated medication infusion and analyte monitoring system |
| US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
| US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
| US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
| US7620437B2 (en) | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
| US20060272652A1 (en) * | 2005-06-03 | 2006-12-07 | Medtronic Minimed, Inc. | Virtual patient software system for educating and treating individuals with diabetes |
| US20070033074A1 (en) * | 2005-06-03 | 2007-02-08 | Medtronic Minimed, Inc. | Therapy management system |
| US20070016449A1 (en) * | 2005-06-29 | 2007-01-18 | Gary Cohen | Flexible glucose analysis using varying time report deltas and configurable glucose target ranges |
| US20070066956A1 (en) * | 2005-07-27 | 2007-03-22 | Medtronic Minimed, Inc. | Systems and methods for entering temporary basal rate pattern in an infusion device |
| US7737581B2 (en) | 2005-08-16 | 2010-06-15 | Medtronic Minimed, Inc. | Method and apparatus for predicting end of battery life |
| US20070093786A1 (en) * | 2005-08-16 | 2007-04-26 | Medtronic Minimed, Inc. | Watch controller for a medical device |
| US20090227855A1 (en) | 2005-08-16 | 2009-09-10 | Medtronic Minimed, Inc. | Controller device for an infusion pump |
| US20080314395A1 (en) | 2005-08-31 | 2008-12-25 | Theuniversity Of Virginia Patent Foundation | Accuracy of Continuous Glucose Sensors |
| US7713240B2 (en) | 2005-09-13 | 2010-05-11 | Medtronic Minimed, Inc. | Modular external infusion device |
| US9072476B2 (en) | 2005-09-23 | 2015-07-07 | Medtronic Minimed, Inc. | Flexible sensor apparatus |
| US7725148B2 (en) | 2005-09-23 | 2010-05-25 | Medtronic Minimed, Inc. | Sensor with layered electrodes |
| US8880138B2 (en) | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
| US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
| US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
| US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
| US20090136827A1 (en) * | 2005-11-02 | 2009-05-28 | St. Louis University | Enzymes immobilized in hydrophobically modified polysaccharides |
| CA2627650A1 (en) * | 2005-11-02 | 2007-07-26 | St. Louis University | Direct electron transfer using enzymes in bioanodes, biocathodes, and biofuel cells |
| US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
| US20070179436A1 (en) * | 2005-12-21 | 2007-08-02 | Braig James R | Analyte detection system with periodic sample draw and laboratory-grade analyzer |
| US8160670B2 (en) | 2005-12-28 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent |
| EP1968432A4 (en) | 2005-12-28 | 2009-10-21 | Abbott Diabetes Care Inc | Medical device insertion |
| US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
| US8515518B2 (en) | 2005-12-28 | 2013-08-20 | Abbott Diabetes Care Inc. | Analyte monitoring |
| US7985330B2 (en) | 2005-12-30 | 2011-07-26 | Medtronic Minimed, Inc. | Method and system for detecting age, hydration, and functional states of sensors using electrochemical impedance spectroscopy |
| US20070169533A1 (en) * | 2005-12-30 | 2007-07-26 | Medtronic Minimed, Inc. | Methods and systems for detecting the hydration of sensors |
| US20070173712A1 (en) * | 2005-12-30 | 2007-07-26 | Medtronic Minimed, Inc. | Method of and system for stabilization of sensors |
| US7774038B2 (en) * | 2005-12-30 | 2010-08-10 | Medtronic Minimed, Inc. | Real-time self-calibrating sensor system and method |
| US8114268B2 (en) * | 2005-12-30 | 2012-02-14 | Medtronic Minimed, Inc. | Method and system for remedying sensor malfunctions detected by electrochemical impedance spectroscopy |
| US8114269B2 (en) | 2005-12-30 | 2012-02-14 | Medtronic Minimed, Inc. | System and method for determining the point of hydration and proper time to apply potential to a glucose sensor |
| US9757061B2 (en) | 2006-01-17 | 2017-09-12 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
| US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
| US8344966B2 (en) | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
| US7826879B2 (en) | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
| US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
| US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
| US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
| US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
| US8224415B2 (en) | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
| US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
| US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
| US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
| US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
| US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
| US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
| US7801582B2 (en) | 2006-03-31 | 2010-09-21 | Abbott Diabetes Care Inc. | Analyte monitoring and management system and methods therefor |
| US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
| US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
| US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
| US20100012049A1 (en) * | 2006-04-12 | 2010-01-21 | Jms Co., Ltd | Cavitation heating system and method |
| US8073008B2 (en) | 2006-04-28 | 2011-12-06 | Medtronic Minimed, Inc. | Subnetwork synchronization and variable transmit synchronization techniques for a wireless medical device network |
| US20070255125A1 (en) | 2006-04-28 | 2007-11-01 | Moberg Sheldon B | Monitor devices for networked fluid infusion systems |
| WO2007143225A2 (en) | 2006-06-07 | 2007-12-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
| US7699973B2 (en) * | 2006-06-30 | 2010-04-20 | Abbott Diabetes Care Inc. | Rapid analyte measurement assay |
| GB0613500D0 (en) * | 2006-07-07 | 2006-08-16 | Lectus Therapeutics Ltd | Apparatus and Methods |
| US20090305089A1 (en) * | 2006-07-14 | 2009-12-10 | Akermin, Inc. | Organelles in bioanodes, biocathodes, and biofuel cells |
| MX2009002830A (en) | 2006-09-22 | 2009-05-28 | Bayer Healthcare Llc | Biosensor system having enhanced stability and hematocrit performance. |
| US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| EP2106238A4 (en) | 2006-10-26 | 2011-03-09 | Abbott Diabetes Care Inc | Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors |
| US20080119702A1 (en) * | 2006-10-31 | 2008-05-22 | Abbott Diabetes Care, Inc. | Analyte meter having alert, alarm and test reminder capabilities and methods of use |
| US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
| US20080119710A1 (en) * | 2006-10-31 | 2008-05-22 | Abbott Diabetes Care, Inc. | Medical devices and methods of using the same |
| US20110039164A1 (en) * | 2006-11-06 | 2011-02-17 | Akermin, Inc. | Bioanode and biocathode stack assemblies |
| WO2008150280A1 (en) | 2006-11-30 | 2008-12-11 | Abbott Diabetes Care Inc. | Lyotropic liquid crystal coated analyte monitoring device and methods of use |
| US20080139910A1 (en) * | 2006-12-06 | 2008-06-12 | Metronic Minimed, Inc. | Analyte sensor and method of using the same |
| US20080214912A1 (en) * | 2007-01-10 | 2008-09-04 | Glucose Sensing Technologies, Llc | Blood Glucose Monitoring System And Method |
| US8808515B2 (en) | 2007-01-31 | 2014-08-19 | Abbott Diabetes Care Inc. | Heterocyclic nitrogen containing polymers coated analyte monitoring device and methods of use |
| US10154804B2 (en) * | 2007-01-31 | 2018-12-18 | Medtronic Minimed, Inc. | Model predictive method and system for controlling and supervising insulin infusion |
| US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
| US8121857B2 (en) | 2007-02-15 | 2012-02-21 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
| US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
| US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
| DE602007000964D1 (en) * | 2007-02-28 | 2009-06-04 | Gen Life Biotechnology Co Ltd | Measuring element for the detection of total cholesterol in a blood sample |
| US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
| CA2681412A1 (en) | 2007-03-26 | 2008-10-02 | Dexcom, Inc. | Analyte sensor |
| CA2683953C (en) | 2007-04-14 | 2016-08-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
| CA2683959C (en) | 2007-04-14 | 2017-08-29 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
| WO2008128210A1 (en) | 2007-04-14 | 2008-10-23 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
| CA2683721C (en) | 2007-04-14 | 2017-05-23 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
| EP2146625B1 (en) | 2007-04-14 | 2019-08-14 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
| ES2817503T3 (en) | 2007-04-14 | 2021-04-07 | Abbott Diabetes Care Inc | Procedure and apparatus for providing data processing and control in a medical communication system |
| US20080269714A1 (en) | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
| US8080385B2 (en) | 2007-05-03 | 2011-12-20 | Abbott Diabetes Care Inc. | Crosslinked adduct of polyaniline and polymer acid containing redox enzyme for electrochemical sensor |
| US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
| US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US7996158B2 (en) | 2007-05-14 | 2011-08-09 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| WO2008150917A1 (en) | 2007-05-31 | 2008-12-11 | Abbott Diabetes Care, Inc. | Insertion devices and methods |
| WO2008154312A1 (en) | 2007-06-08 | 2008-12-18 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
| JP5680960B2 (en) | 2007-06-21 | 2015-03-04 | アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． | Health care device and method |
| US8617069B2 (en) | 2007-06-21 | 2013-12-31 | Abbott Diabetes Care Inc. | Health monitor |
| US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
| US7768386B2 (en) | 2007-07-31 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
| WO2009032760A2 (en) | 2007-08-30 | 2009-03-12 | Pepex Biomedical Llc | Electrochmical sensor and method for manufacturing |
| US9044178B2 (en) | 2007-08-30 | 2015-06-02 | Pepex Biomedical, Llc | Electrochemical sensor and method for manufacturing |
| CN102308206A (en) * | 2007-09-17 | 2012-01-04 | 红象牙有限责任公司 | Self-actuating signal producing detection devices and methods |
| US9452258B2 (en) | 2007-10-09 | 2016-09-27 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
| US8163146B2 (en) * | 2007-10-12 | 2012-04-24 | Abbott Diabetes Care Inc. | Mediator stabilized reagent compositions for use in biosensor electrodes |
| US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
| US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
| US8216138B1 (en) | 2007-10-23 | 2012-07-10 | Abbott Diabetes Care Inc. | Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration |
| BRPI0820721A2 (en) | 2007-12-10 | 2015-06-16 | Bayer Healthcare Llc | Reagents and methods for detecting analytes |
| US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
| US8313467B2 (en) | 2007-12-27 | 2012-11-20 | Medtronic Minimed, Inc. | Reservoir pressure equalization systems and methods |
| US8431011B2 (en) | 2008-01-31 | 2013-04-30 | Abbott Diabetes Care Inc. | Method for automatically and rapidly distinguishing between control and sample solutions in a biosensor strip |
| WO2009105709A1 (en) | 2008-02-21 | 2009-08-27 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
| US8252229B2 (en) | 2008-04-10 | 2012-08-28 | Abbott Diabetes Care Inc. | Method and system for sterilizing an analyte sensor |
| US9295786B2 (en) | 2008-05-28 | 2016-03-29 | Medtronic Minimed, Inc. | Needle protective device for subcutaneous sensors |
| US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
| US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
| US7826382B2 (en) | 2008-05-30 | 2010-11-02 | Abbott Diabetes Care Inc. | Close proximity communication device and methods |
| WO2010009172A1 (en) | 2008-07-14 | 2010-01-21 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
| US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
| US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
| US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
| US8622988B2 (en) | 2008-08-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Variable rate closed loop control and methods |
| EP2326944B1 (en) | 2008-09-19 | 2020-08-19 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
| US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
| US8208973B2 (en) | 2008-11-05 | 2012-06-26 | Medtronic Minimed, Inc. | System and method for variable beacon timing with wireless devices |
| US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
| WO2010056878A2 (en) | 2008-11-14 | 2010-05-20 | Pepex Biomedical, Llc | Electrochemical sensor module |
| US20110266149A1 (en) | 2008-11-14 | 2011-11-03 | Pepex Biomedical, Llc | Electrochemical sensor module |
| US8951377B2 (en) | 2008-11-14 | 2015-02-10 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor module |
| US8506740B2 (en) | 2008-11-14 | 2013-08-13 | Pepex Biomedical, Llc | Manufacturing electrochemical sensor module |
| US9330237B2 (en) * | 2008-12-24 | 2016-05-03 | Medtronic Minimed, Inc. | Pattern recognition and filtering in a therapy management system |
| US20100160740A1 (en) * | 2008-12-24 | 2010-06-24 | Gary Cohen | Use of Patterns in a Therapy Management System |
| US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
| US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
| US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
| US20100198188A1 (en) * | 2009-02-05 | 2010-08-05 | Abbott Diabetes Care Inc. | Devices and Methods for Metering Insoluble Active Agent Particles |
| US20100213057A1 (en) | 2009-02-26 | 2010-08-26 | Benjamin Feldman | Self-Powered Analyte Sensor |
| US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
| WO2010121229A1 (en) | 2009-04-16 | 2010-10-21 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
| US8758583B2 (en) * | 2009-04-28 | 2014-06-24 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
| US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
| WO2010129375A1 (en) | 2009-04-28 | 2010-11-11 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
| US8483967B2 (en) | 2009-04-29 | 2013-07-09 | Abbott Diabetes Care Inc. | Method and system for providing real time analyte sensor calibration with retrospective backfill |
| EP2424426B1 (en) | 2009-04-29 | 2020-01-08 | Abbott Diabetes Care, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
| US9184490B2 (en) | 2009-05-29 | 2015-11-10 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
| US8595607B2 (en) | 2009-06-04 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
| US8613892B2 (en) | 2009-06-30 | 2013-12-24 | Abbott Diabetes Care Inc. | Analyte meter with a moveable head and methods of using the same |
| US8437827B2 (en) * | 2009-06-30 | 2013-05-07 | Abbott Diabetes Care Inc. | Extruded analyte sensors and methods of using same |
| US8298158B2 (en) * | 2009-06-30 | 2012-10-30 | Abbott Diabetes Care Inc. | Integrated devices having extruded electrode structures and methods of using same |
| US8344847B2 (en) | 2009-07-09 | 2013-01-01 | Medtronic Minimed, Inc. | Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device |
| EP3936032A1 (en) | 2009-07-23 | 2022-01-12 | Abbott Diabetes Care, Inc. | Real time management of data relating to physiological control of glucose levels |
| DK3689237T3 (en) | 2009-07-23 | 2021-08-16 | Abbott Diabetes Care Inc | Method of preparation and system for continuous analyte measurement |
| WO2011014851A1 (en) | 2009-07-31 | 2011-02-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
| US9125603B2 (en) * | 2009-08-11 | 2015-09-08 | Abbott Diabetes Care Inc. | Analyte sensor ports |
| WO2011026148A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
| EP3923295A1 (en) | 2009-08-31 | 2021-12-15 | Abbott Diabetes Care, Inc. | Medical devices and methods |
| US8357276B2 (en) | 2009-08-31 | 2013-01-22 | Abbott Diabetes Care Inc. | Small volume test strips with large sample fill ports, supported test strips, and methods of making and using same |
| US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
| ES2912584T3 (en) | 2009-08-31 | 2022-05-26 | Abbott Diabetes Care Inc | A glucose monitoring system and method |
| US8487758B2 (en) | 2009-09-02 | 2013-07-16 | Medtronic Minimed, Inc. | Medical device having an intelligent alerting scheme, and related operating methods |
| WO2011041469A1 (en) | 2009-09-29 | 2011-04-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
| WO2011041531A1 (en) | 2009-09-30 | 2011-04-07 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
| WO2011053881A1 (en) | 2009-10-30 | 2011-05-05 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
| US8386042B2 (en) | 2009-11-03 | 2013-02-26 | Medtronic Minimed, Inc. | Omnidirectional accelerometer device and medical device incorporating same |
| US8574201B2 (en) | 2009-12-22 | 2013-11-05 | Medtronic Minimed, Inc. | Syringe piston with check valve seal |
| US8755269B2 (en) | 2009-12-23 | 2014-06-17 | Medtronic Minimed, Inc. | Ranking and switching of wireless channels in a body area network of medical devices |
| US8828330B2 (en) | 2010-01-28 | 2014-09-09 | Abbott Diabetes Care Inc. | Universal test strip port |
| USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
| WO2011112753A1 (en) | 2010-03-10 | 2011-09-15 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
| ES2881798T3 (en) | 2010-03-24 | 2021-11-30 | Abbott Diabetes Care Inc | Medical device inserters and medical device insertion and use procedures |
| US9320432B2 (en) | 2010-04-16 | 2016-04-26 | Abbott Diabetes Care Inc. | Analyte meter communication module |
| WO2011133768A1 (en) | 2010-04-22 | 2011-10-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods related to analyte monitoring and management |
| JP5753720B2 (en) | 2010-04-22 | 2015-07-22 | アークレイ株式会社 | Biosensor |
| US8726266B2 (en) | 2010-05-24 | 2014-05-13 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
| US8635046B2 (en) | 2010-06-23 | 2014-01-21 | Abbott Diabetes Care Inc. | Method and system for evaluating analyte sensor response characteristics |
| US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
| US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
| US9085790B2 (en) | 2010-07-28 | 2015-07-21 | Abbott Diabetes Care Inc. | Analyte sensors having temperature independent membranes |
| US11213226B2 (en) | 2010-10-07 | 2022-01-04 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
| US8603032B2 (en) | 2010-10-15 | 2013-12-10 | Medtronic Minimed, Inc. | Medical device with membrane keypad sealing element, and related manufacturing method |
| US8603033B2 (en) | 2010-10-15 | 2013-12-10 | Medtronic Minimed, Inc. | Medical device and related assembly having an offset element for a piezoelectric speaker |
| US8562565B2 (en) | 2010-10-15 | 2013-10-22 | Medtronic Minimed, Inc. | Battery shock absorber for a portable medical device |
| US8495918B2 (en) | 2010-10-20 | 2013-07-30 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
| US8474332B2 (en) | 2010-10-20 | 2013-07-02 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
| US8479595B2 (en) | 2010-10-20 | 2013-07-09 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
| WO2012058237A1 (en) | 2010-10-26 | 2012-05-03 | Abbott Diabetes Care Inc. | Analyte measurement devices and systems, and components and methods related thereto |
| US8702928B2 (en) | 2010-11-22 | 2014-04-22 | Abbott Diabetes Care Inc. | Modular analyte measurement system with extendable strip port |
| US9713440B2 (en) | 2010-12-08 | 2017-07-25 | Abbott Diabetes Care Inc. | Modular analyte measurement systems, modular components thereof and related methods |
| US8628510B2 (en) | 2010-12-22 | 2014-01-14 | Medtronic Minimed, Inc. | Monitoring the operating health of a force sensor in a fluid infusion device |
| US8690855B2 (en) | 2010-12-22 | 2014-04-08 | Medtronic Minimed, Inc. | Fluid reservoir seating procedure for a fluid infusion device |
| US8197444B1 (en) | 2010-12-22 | 2012-06-12 | Medtronic Minimed, Inc. | Monitoring the seating status of a fluid reservoir in a fluid infusion device |
| US8469942B2 (en) | 2010-12-22 | 2013-06-25 | Medtronic Minimed, Inc. | Occlusion detection for a fluid infusion device |
| AU2012212655B2 (en) | 2011-01-06 | 2015-12-24 | Pepex Biomedical, Inc. | Sensor module with enhanced capillary flow |
| AU2012204298B2 (en) | 2011-01-06 | 2015-12-17 | Pepex Biomedical, Inc. | Sensor array mounted on flexible carrier |
| WO2012108936A1 (en) | 2011-02-11 | 2012-08-16 | Abbott Diabetes Care Inc. | Data synchronization between two or more analyte detecting devices in a database |
| WO2012108938A1 (en) | 2011-02-11 | 2012-08-16 | Abbott Diabetes Care Inc. | Software applications residing on handheld analyte determining devices |
| US9393399B2 (en) | 2011-02-22 | 2016-07-19 | Medtronic Minimed, Inc. | Sealing assembly for a fluid reservoir of a fluid infusion device |
| US20120211946A1 (en) | 2011-02-22 | 2012-08-23 | Medtronic Minimed, Inc. | Sealing element for a hollow needle of a fluid infusion device |
| US9283318B2 (en) | 2011-02-22 | 2016-03-15 | Medtronic Minimed, Inc. | Flanged sealing element and needle guide pin assembly for a fluid infusion device having a needled fluid reservoir |
| US9463309B2 (en) | 2011-02-22 | 2016-10-11 | Medtronic Minimed, Inc. | Sealing assembly and structure for a fluid infusion device having a needled fluid reservoir |
| US8614596B2 (en) | 2011-02-28 | 2013-12-24 | Medtronic Minimed, Inc. | Systems and methods for initializing a voltage bus and medical devices incorporating same |
| US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
| CN103619255B (en) | 2011-02-28 | 2016-11-02 | 雅培糖尿病护理公司 | The device that associates with analyte monitoring device, system and method and combine their device |
| US9101305B2 (en) | 2011-03-09 | 2015-08-11 | Medtronic Minimed, Inc. | Glucose sensor product and related manufacturing and packaging methods |
| US10010273B2 (en) | 2011-03-10 | 2018-07-03 | Abbott Diabetes Care, Inc. | Multi-function analyte monitor device and methods of use |
| US8564447B2 (en) | 2011-03-18 | 2013-10-22 | Medtronic Minimed, Inc. | Battery life indication techniques for an electronic device |
| US9018893B2 (en) | 2011-03-18 | 2015-04-28 | Medtronic Minimed, Inc. | Power control techniques for an electronic device |
| DK3575796T3 (en) | 2011-04-15 | 2021-01-18 | Dexcom Inc | ADVANCED ANALYZE SENSOR CALIBRATION AND ERROR DETECTION |
| EP2699175A4 (en) | 2011-04-20 | 2014-08-13 | Abbott Diabetes Care Inc | Analyte monitoring devices and methods |
| WO2012159040A2 (en) | 2011-05-19 | 2012-11-22 | Pepex Biomedical Inc. | Fluid management and patient monitoring system |
| WO2012162151A2 (en) | 2011-05-20 | 2012-11-29 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor modules |
| EP4122384A1 (en) | 2011-06-16 | 2023-01-25 | Abbott Diabetes Care, Inc. | Temperature-compensated analyte monitoring devices, systems, and methods thereof |
| WO2013003735A1 (en) | 2011-06-30 | 2013-01-03 | Abbott Diabetes Care Inc. | Methods for generating hybrid analyte level output, and devices and systems related thereto |
| US11087868B2 (en) | 2011-09-28 | 2021-08-10 | Abbott Diabetes Care Inc. | Methods, devices and systems for analyte monitoring management |
| US9622689B2 (en) | 2011-09-28 | 2017-04-18 | Abbott Diabetes Care Inc. | Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto |
| USD680454S1 (en) | 2011-10-25 | 2013-04-23 | Abbott Diabetes Care Inc. | Analyte meter and strip port |
| WO2013066849A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
| WO2013066873A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
| US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
| US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
| US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
| WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
| US8887911B2 (en) | 2011-12-09 | 2014-11-18 | Abbott Diabetes Care Inc. | Packages and kits for analyte monitoring devices, and methods related thereto |
| FI3300658T3 (en) | 2011-12-11 | 2024-03-01 | Abbott Diabetes Care Inc | Analyte sensor methods |
| US9610401B2 (en) | 2012-01-13 | 2017-04-04 | Medtronic Minimed, Inc. | Infusion set component with modular fluid channel element |
| US8603026B2 (en) | 2012-03-20 | 2013-12-10 | Medtronic Minimed, Inc. | Dynamic pulse-width modulation motor control and medical device incorporating same |
| US8523803B1 (en) | 2012-03-20 | 2013-09-03 | Medtronic Minimed, Inc. | Motor health monitoring and medical device incorporating same |
| US8603027B2 (en) | 2012-03-20 | 2013-12-10 | Medtronic Minimed, Inc. | Occlusion detection using pulse-width modulation and medical device incorporating same |
| EP2840958B1 (en) | 2012-04-24 | 2020-09-30 | Abbott Diabetes Care, Inc. | Methods of lag-compensation for analyte measurements |
| US20130338629A1 (en) | 2012-06-07 | 2013-12-19 | Medtronic Minimed, Inc. | Diabetes therapy management system for recommending basal pattern adjustments |
| US9333292B2 (en) | 2012-06-26 | 2016-05-10 | Medtronic Minimed, Inc. | Mechanically actuated fluid infusion device |
| US9535027B2 (en) | 2012-07-25 | 2017-01-03 | Abbott Diabetes Care Inc. | Analyte sensors and methods of using same |
| US8808269B2 (en) | 2012-08-21 | 2014-08-19 | Medtronic Minimed, Inc. | Reservoir plunger position monitoring and medical device incorporating same |
| US10130767B2 (en) | 2012-08-30 | 2018-11-20 | Medtronic Minimed, Inc. | Sensor model supervisor for a closed-loop insulin infusion system |
| US9364609B2 (en) | 2012-08-30 | 2016-06-14 | Medtronic Minimed, Inc. | Insulin on board compensation for a closed-loop insulin infusion system |
| US9662445B2 (en) | 2012-08-30 | 2017-05-30 | Medtronic Minimed, Inc. | Regulating entry into a closed-loop operating mode of an insulin infusion system |
| EP3395252A1 (en) | 2012-08-30 | 2018-10-31 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
| US10496797B2 (en) | 2012-08-30 | 2019-12-03 | Medtronic Minimed, Inc. | Blood glucose validation for a closed-loop operating mode of an insulin infusion system |
| US9849239B2 (en) | 2012-08-30 | 2017-12-26 | Medtronic Minimed, Inc. | Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system |
| US9623179B2 (en) | 2012-08-30 | 2017-04-18 | Medtronic Minimed, Inc. | Safeguarding techniques for a closed-loop insulin infusion system |
| US9878096B2 (en) | 2012-08-30 | 2018-01-30 | Medtronic Minimed, Inc. | Generation of target glucose values for a closed-loop operating mode of an insulin infusion system |
| US20140206966A1 (en) * | 2012-09-17 | 2014-07-24 | Google Inc. | Sensor |
| US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
| US10004439B2 (en) | 2012-09-21 | 2018-06-26 | Abbott Diabetes Care Inc. | In vivo sensors having ceria nanoparticle electrodes |
| US9907492B2 (en) | 2012-09-26 | 2018-03-06 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
| US8870818B2 (en) | 2012-11-15 | 2014-10-28 | Medtronic Minimed, Inc. | Systems and methods for alignment and detection of a consumable component |
| WO2014089058A1 (en) | 2012-12-03 | 2014-06-12 | Pepex Biomedical, Inc. | Sensor module and method of using a sensor module |
| US9107994B2 (en) | 2013-01-18 | 2015-08-18 | Medtronic Minimed, Inc. | Systems for fluid reservoir retention |
| US9033924B2 (en) | 2013-01-18 | 2015-05-19 | Medtronic Minimed, Inc. | Systems for fluid reservoir retention |
| US9522223B2 (en) | 2013-01-18 | 2016-12-20 | Medtronic Minimed, Inc. | Systems for fluid reservoir retention |
| US9308321B2 (en) | 2013-02-18 | 2016-04-12 | Medtronic Minimed, Inc. | Infusion device having gear assembly initialization |
| EP2967344A4 (en) | 2013-03-15 | 2016-11-23 | Abbott Diabetes Care Inc | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
| US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
| WO2014152034A1 (en) | 2013-03-15 | 2014-09-25 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
| US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
| US8920381B2 (en) | 2013-04-12 | 2014-12-30 | Medtronic Minimed, Inc. | Infusion set with improved bore configuration |
| CN109222991B (en) | 2013-04-30 | 2022-04-19 | 雅培糖尿病护理公司 | Method for supplying power in living body analyte monitoring environment and monitoring system |
| US9433731B2 (en) | 2013-07-19 | 2016-09-06 | Medtronic Minimed, Inc. | Detecting unintentional motor motion and infusion device incorporating same |
| US9402949B2 (en) | 2013-08-13 | 2016-08-02 | Medtronic Minimed, Inc. | Detecting conditions associated with medical device operations using matched filters |
| US9880528B2 (en) | 2013-08-21 | 2018-01-30 | Medtronic Minimed, Inc. | Medical devices and related updating methods and systems |
| US9889257B2 (en) | 2013-08-21 | 2018-02-13 | Medtronic Minimed, Inc. | Systems and methods for updating medical devices |
| US9259528B2 (en) | 2013-08-22 | 2016-02-16 | Medtronic Minimed, Inc. | Fluid infusion device with safety coupling |
| US9750878B2 (en) | 2013-12-11 | 2017-09-05 | Medtronic Minimed, Inc. | Closed-loop control of glucose according to a predicted blood glucose trajectory |
| US9750877B2 (en) | 2013-12-11 | 2017-09-05 | Medtronic Minimed, Inc. | Predicted time to assess and/or control a glycemic state |
| US10105488B2 (en) | 2013-12-12 | 2018-10-23 | Medtronic Minimed, Inc. | Predictive infusion device operations and related methods and systems |
| US9849240B2 (en) | 2013-12-12 | 2017-12-26 | Medtronic Minimed, Inc. | Data modification for predictive operations and devices incorporating same |
| US9694132B2 (en) | 2013-12-19 | 2017-07-04 | Medtronic Minimed, Inc. | Insertion device for insertion set |
| CA2933166C (en) | 2013-12-31 | 2020-10-27 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
| US9399096B2 (en) | 2014-02-06 | 2016-07-26 | Medtronic Minimed, Inc. | Automatic closed-loop control adjustments and infusion systems incorporating same |
| US9861748B2 (en) | 2014-02-06 | 2018-01-09 | Medtronic Minimed, Inc. | User-configurable closed-loop notifications and infusion systems incorporating same |
| US10034976B2 (en) | 2014-03-24 | 2018-07-31 | Medtronic Minimed, Inc. | Fluid infusion patch pump device with automatic fluid system priming feature |
| EP4151150A1 (en) | 2014-03-30 | 2023-03-22 | Abbott Diabetes Care, Inc. | Method and apparatus for determining meal start and peak events in analyte monitoring systems |
| US10001450B2 (en) | 2014-04-18 | 2018-06-19 | Medtronic Minimed, Inc. | Nonlinear mapping technique for a physiological characteristic sensor |
| US10232113B2 (en) | 2014-04-24 | 2019-03-19 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for regulating insulin on board |
| US10275572B2 (en) | 2014-05-01 | 2019-04-30 | Medtronic Minimed, Inc. | Detecting blockage of a reservoir cavity during a seating operation of a fluid infusion device |
| US9681828B2 (en) | 2014-05-01 | 2017-06-20 | Medtronic Minimed, Inc. | Physiological characteristic sensors and methods for forming such sensors |
| US10152049B2 (en) | 2014-05-19 | 2018-12-11 | Medtronic Minimed, Inc. | Glucose sensor health monitoring and related methods and systems |
| US10274349B2 (en) | 2014-05-19 | 2019-04-30 | Medtronic Minimed, Inc. | Calibration factor adjustments for infusion devices and related methods and systems |
| US10007765B2 (en) | 2014-05-19 | 2018-06-26 | Medtronic Minimed, Inc. | Adaptive signal processing for infusion devices and related methods and systems |
| US11045124B2 (en) | 2014-06-04 | 2021-06-29 | Pepex Biomedical, Inc. | Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology |
| US20150377813A1 (en) * | 2014-06-30 | 2015-12-31 | Stmicroelectronics S.R.L. | Semiconductor gas sensor device and manufacturing method thereof |
| CA2957676A1 (en) | 2014-08-15 | 2016-02-18 | Abbott Diabetes Care Inc. | Temperature insensitive in vivo analyte devices, methods and systems |
| US9833563B2 (en) | 2014-09-26 | 2017-12-05 | Medtronic Minimed, Inc. | Systems for managing reservoir chamber pressure |
| US9839753B2 (en) | 2014-09-26 | 2017-12-12 | Medtronic Minimed, Inc. | Systems for managing reservoir chamber pressure |
| US10279126B2 (en) | 2014-10-07 | 2019-05-07 | Medtronic Minimed, Inc. | Fluid conduit assembly with gas trapping filter in the fluid flow path |
| US10598624B2 (en) | 2014-10-23 | 2020-03-24 | Abbott Diabetes Care Inc. | Electrodes having at least one sensing structure and methods for making and using the same |
| US9833564B2 (en) | 2014-11-25 | 2017-12-05 | Medtronic Minimed, Inc. | Fluid conduit assembly with air venting features |
| US10195341B2 (en) | 2014-11-26 | 2019-02-05 | Medtronic Minimed, Inc. | Systems and methods for fluid infusion device with automatic reservoir fill |
| US9987420B2 (en) | 2014-11-26 | 2018-06-05 | Medtronic Minimed, Inc. | Systems and methods for fluid infusion device with automatic reservoir fill |
| US9943645B2 (en) | 2014-12-04 | 2018-04-17 | Medtronic Minimed, Inc. | Methods for operating mode transitions and related infusion devices and systems |
| US9636453B2 (en) | 2014-12-04 | 2017-05-02 | Medtronic Minimed, Inc. | Advance diagnosis of infusion device operating mode viability |
| US9937292B2 (en) | 2014-12-09 | 2018-04-10 | Medtronic Minimed, Inc. | Systems for filling a fluid infusion device reservoir |
| US10265031B2 (en) | 2014-12-19 | 2019-04-23 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for automatic alert clearing |
| US10307535B2 (en) | 2014-12-19 | 2019-06-04 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for preemptive alerting |
| US10307528B2 (en) | 2015-03-09 | 2019-06-04 | Medtronic Minimed, Inc. | Extensible infusion devices and related methods |
| US10449298B2 (en) | 2015-03-26 | 2019-10-22 | Medtronic Minimed, Inc. | Fluid injection devices and related methods |
| US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
| WO2016183493A1 (en) | 2015-05-14 | 2016-11-17 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
| US10137243B2 (en) | 2015-05-26 | 2018-11-27 | Medtronic Minimed, Inc. | Infusion devices with distributed motor control and related operating methods |
| US9999721B2 (en) | 2015-05-26 | 2018-06-19 | Medtronic Minimed, Inc. | Error handling in infusion devices with distributed motor control and related operating methods |
| US10575767B2 (en) | 2015-05-29 | 2020-03-03 | Medtronic Minimed, Inc. | Method for monitoring an analyte, analyte sensor and analyte monitoring apparatus |
| EP3307164B1 (en) | 2015-06-15 | 2021-05-12 | Abbott Diabetes Care Inc. | Stabilized lactate responsive enzymes, electrodes and sensors, and methods for making and using the same |
| US9879668B2 (en) | 2015-06-22 | 2018-01-30 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and an optical sensor |
| US9878095B2 (en) | 2015-06-22 | 2018-01-30 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and multiple sensor contact elements |
| US9993594B2 (en) | 2015-06-22 | 2018-06-12 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and rotor position sensors |
| US10010668B2 (en) | 2015-06-22 | 2018-07-03 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and a force sensor |
| US9987425B2 (en) | 2015-06-22 | 2018-06-05 | Medtronic Minimed, Inc. | Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and sensor contact elements |
| US10888272B2 (en) | 2015-07-10 | 2021-01-12 | Abbott Diabetes Care Inc. | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation |
| WO2017011346A1 (en) | 2015-07-10 | 2017-01-19 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
| US10478557B2 (en) | 2015-08-21 | 2019-11-19 | Medtronic Minimed, Inc. | Personalized parameter modeling methods and related devices and systems |
| US10293108B2 (en) | 2015-08-21 | 2019-05-21 | Medtronic Minimed, Inc. | Infusion devices and related patient ratio adjustment methods |
| US10201657B2 (en) | 2015-08-21 | 2019-02-12 | Medtronic Minimed, Inc. | Methods for providing sensor site rotation feedback and related infusion devices and systems |
| US10463297B2 (en) | 2015-08-21 | 2019-11-05 | Medtronic Minimed, Inc. | Personalized event detection methods and related devices and systems |
| US10664569B2 (en) | 2015-08-21 | 2020-05-26 | Medtronic Minimed, Inc. | Data analytics and generation of recommendations for controlling glycemic outcomes associated with tracked events |
| US10117992B2 (en) | 2015-09-29 | 2018-11-06 | Medtronic Minimed, Inc. | Infusion devices and related rescue detection methods |
| US11666702B2 (en) | 2015-10-19 | 2023-06-06 | Medtronic Minimed, Inc. | Medical devices and related event pattern treatment recommendation methods |
| US11501867B2 (en) | 2015-10-19 | 2022-11-15 | Medtronic Minimed, Inc. | Medical devices and related event pattern presentation methods |
| US10146911B2 (en) | 2015-10-23 | 2018-12-04 | Medtronic Minimed, Inc. | Medical devices and related methods and systems for data transfer |
| US10037722B2 (en) | 2015-11-03 | 2018-07-31 | Medtronic Minimed, Inc. | Detecting breakage in a display element |
| US10449306B2 (en) | 2015-11-25 | 2019-10-22 | Medtronics Minimed, Inc. | Systems for fluid delivery with wicking membrane |
| EP3423591B1 (en) | 2016-03-04 | 2023-11-01 | Abbott Diabetes Care Inc. | Nad(p)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same |
| US10589038B2 (en) | 2016-04-27 | 2020-03-17 | Medtronic Minimed, Inc. | Set connector systems for venting a fluid reservoir |
| US10753900B2 (en) | 2016-06-30 | 2020-08-25 | University Of Connecticut | Real-time in situ sensing of water-related parameters using micro-electrode array |
| US11097051B2 (en) | 2016-11-04 | 2021-08-24 | Medtronic Minimed, Inc. | Methods and apparatus for detecting and reacting to insufficient hypoglycemia response |
| US10238030B2 (en) | 2016-12-06 | 2019-03-26 | Medtronic Minimed, Inc. | Wireless medical device with a complementary split ring resonator arrangement for suppression of electromagnetic interference |
| US10272201B2 (en) | 2016-12-22 | 2019-04-30 | Medtronic Minimed, Inc. | Insertion site monitoring methods and related infusion devices and systems |
| CN110461217B (en) | 2017-01-23 | 2022-09-16 | 雅培糖尿病护理公司 | Systems, devices, and methods for analyte sensor insertion |
| US10532165B2 (en) | 2017-01-30 | 2020-01-14 | Medtronic Minimed, Inc. | Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device |
| US10500135B2 (en) | 2017-01-30 | 2019-12-10 | Medtronic Minimed, Inc. | Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device |
| US10552580B2 (en) | 2017-02-07 | 2020-02-04 | Medtronic Minimed, Inc. | Infusion system consumables and related calibration methods |
| US10363365B2 (en) | 2017-02-07 | 2019-07-30 | Medtronic Minimed, Inc. | Infusion devices and related consumable calibration methods |
| US11207463B2 (en) | 2017-02-21 | 2021-12-28 | Medtronic Minimed, Inc. | Apparatuses, systems, and methods for identifying an infusate in a reservoir of an infusion device |
| US10646649B2 (en) | 2017-02-21 | 2020-05-12 | Medtronic Minimed, Inc. | Infusion devices and fluid identification apparatuses and methods |
| US11596330B2 (en) | 2017-03-21 | 2023-03-07 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
| JP7137589B2 (en) | 2017-06-30 | 2022-09-14 | アボット ダイアベティス ケア インコーポレイテッド | Method and apparatus for analyte detection using electrochemical biosensors |
| GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
| EP3688450A4 (en) * | 2017-09-28 | 2021-07-28 | California Institute of Technology | Method of producing thin enzyme-based sensing layers on planar sensors |
| US20190120785A1 (en) | 2017-10-24 | 2019-04-25 | Dexcom, Inc. | Pre-connected analyte sensors |
| US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
| WO2019089476A1 (en) | 2017-10-30 | 2019-05-09 | Abbott Diabetes Care Inc. | Transcutaneous sensor with dual electrodes and methods of detecting and compensating for withdrawal of a transcutaneous sensor from a patient |
| GB201803997D0 (en) * | 2018-03-13 | 2018-04-25 | Univ Leicester | Electrochemical sensor |
| US11576595B2 (en) | 2018-04-06 | 2023-02-14 | Zense-Life Inc. | Enhanced sensor for a continuous biological monitor |
| CN112292078A (en) | 2018-04-06 | 2021-01-29 | 赞思健康科技有限公司 | Continuous glucose monitoring device |
| AU2019325918B2 (en) * | 2018-08-23 | 2022-08-11 | Abbott Diabetes Care Inc. | Sensors and methods for measuring pH |
| CN110568045A (en) * | 2019-09-12 | 2019-12-13 | 浙江大学山东工业技术研究院 | Electrochemical biosensor capable of rapidly detecting |
| USD957438S1 (en) | 2020-07-29 | 2022-07-12 | Abbott Diabetes Care Inc. | Display screen or portion thereof with graphical user interface |
| EP4256048A2 (en) * | 2020-12-07 | 2023-10-11 | The University of North Carolina at Chapel Hill | Method for measurement in biosensors |
| WO2022164940A1 (en) | 2021-01-26 | 2022-08-04 | Abbott Diabetes Care Inc. | Systems, devices, and methods related to ketone sensors |
| AU2022249389A1 (en) | 2021-04-02 | 2023-11-02 | Dexcom, Inc. | Personalized modeling of blood glucose concentration impacted by individualized sensor characteristics and individualized physiological characteristics |
| WO2022246104A1 (en) * | 2021-05-19 | 2022-11-24 | Arkansas State Universtiy-Jonesboro | Electrochemical sensor for the measurement of glucose concentration |
| WO2023009720A1 (en) * | 2021-07-28 | 2023-02-02 | Cleu Diagnostics, Llc | Oxygen scavengers for electrochemical biosensors |
| WO2023110190A1 (en) | 2021-12-13 | 2023-06-22 | Heraeus Medical Gmbh | Tests and methods for detecting bacterial infection |
Family Cites Families (255)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2059406A (en) * | 1932-07-27 | 1936-11-03 | George A Smith | Fastenings and method of making the same |
| US3260656A (en) * | 1962-09-27 | 1966-07-12 | Corning Glass Works | Method and apparatus for electrolytically determining a species in a fluid |
| US3653841A (en) * | 1969-12-19 | 1972-04-04 | Hoffmann La Roche | Methods and compositions for determining glucose in blood |
| US3776832A (en) | 1970-11-10 | 1973-12-04 | Energetics Science | Electrochemical detection cell |
| US3719564A (en) | 1971-05-10 | 1973-03-06 | Philip Morris Inc | Method of determining a reducible gas concentration and sensor therefor |
| US3837339A (en) * | 1972-02-03 | 1974-09-24 | Whittaker Corp | Blood glucose level monitoring-alarm system and method therefor |
| US3908657A (en) * | 1973-01-15 | 1975-09-30 | Univ Johns Hopkins | System for continuous withdrawal of blood |
| US4100048A (en) * | 1973-09-20 | 1978-07-11 | U.S. Philips Corporation | Polarographic cell |
| US3926760A (en) * | 1973-09-28 | 1975-12-16 | Du Pont | Process for electrophoretic deposition of polymer |
| US3972320A (en) * | 1974-08-12 | 1976-08-03 | Gabor Ujhelyi Kalman | Patient monitoring system |
| US3979274A (en) * | 1975-09-24 | 1976-09-07 | The Yellow Springs Instrument Company, Inc. | Membrane for enzyme electrodes |
| US4016866A (en) * | 1975-12-18 | 1977-04-12 | General Electric Company | Implantable electrochemical sensor |
| US4055175A (en) * | 1976-05-07 | 1977-10-25 | Miles Laboratories, Inc. | Blood glucose control apparatus |
| DE2625834B2 (en) * | 1976-06-09 | 1978-10-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | Method for the determination of substrates or enzyme activities |
| US4059406A (en) * | 1976-07-12 | 1977-11-22 | E D T Supplies Limited | Electrochemical detector system |
| US4076596A (en) * | 1976-10-07 | 1978-02-28 | Leeds & Northrup Company | Apparatus for electrolytically determining a species in a fluid and method of use |
| US4129128A (en) * | 1977-02-23 | 1978-12-12 | Mcfarlane Richard H | Securing device for catheter placement assembly |
| FR2387659A1 (en) * | 1977-04-21 | 1978-11-17 | Armines | GLYCEMIA CONTROL AND REGULATION DEVICE |
| US4098574A (en) * | 1977-08-01 | 1978-07-04 | Eastman Kodak Company | Glucose detection system free from fluoride-ion interference |
| US4178916A (en) * | 1977-09-26 | 1979-12-18 | Mcnamara Elger W | Diabetic insulin alarm system |
| JPS5912135B2 (en) * | 1977-09-28 | 1984-03-21 | 松下電器産業株式会社 | enzyme electrode |
| US4151845A (en) * | 1977-11-25 | 1979-05-01 | Miles Laboratories, Inc. | Blood glucose control apparatus |
| DK151000C (en) * | 1978-02-17 | 1988-06-13 | Radiometer As | PROCEDURE AND APPARATUS FOR DETERMINING A PATIENT'S IN VIVO PLASMA-PH VALUE |
| US4172770A (en) * | 1978-03-27 | 1979-10-30 | Technicon Instruments Corporation | Flow-through electrochemical system analytical method |
| DE2817363C2 (en) * | 1978-04-20 | 1984-01-26 | Siemens AG, 1000 Berlin und 8000 München | Method for determining the concentration of sugar and a suitable electrocatalytic sugar sensor |
| JPS54163225A (en) * | 1978-06-16 | 1979-12-25 | Nissan Motor | Device for controlling number of cylinders to be supplied with fuel |
| US4344438A (en) * | 1978-08-02 | 1982-08-17 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Optical sensor of plasma constituents |
| HU177369B (en) * | 1978-09-08 | 1981-09-28 | Radelkis Electrokemiai | Industrial molecule-selective sensing device and method for producing same |
| US4240438A (en) * | 1978-10-02 | 1980-12-23 | Wisconsin Alumni Research Foundation | Method for monitoring blood glucose levels and elements |
| US4247297A (en) * | 1979-02-23 | 1981-01-27 | Miles Laboratories, Inc. | Test means and method for interference resistant determination of oxidizing substances |
| US4573994A (en) | 1979-04-27 | 1986-03-04 | The Johns Hopkins University | Refillable medication infusion apparatus |
| US4365637A (en) * | 1979-07-05 | 1982-12-28 | Dia-Med, Inc. | Perspiration indicating alarm for diabetics |
| US4401122A (en) * | 1979-08-02 | 1983-08-30 | Children's Hospital Medical Center | Cutaneous methods of measuring body substances |
| US4458686A (en) | 1979-08-02 | 1984-07-10 | Children's Hospital Medical Center | Cutaneous methods of measuring body substances |
| US4450842A (en) | 1980-04-25 | 1984-05-29 | Cordis Corporation | Solid state reference electrode |
| US4340458A (en) * | 1980-06-02 | 1982-07-20 | Joslin Diabetes Center, Inc. | Glucose sensor |
| US4356074A (en) * | 1980-08-25 | 1982-10-26 | The Yellow Springs Instrument Company, Inc. | Substrate specific galactose oxidase enzyme electrodes |
| US4404066A (en) * | 1980-08-25 | 1983-09-13 | The Yellow Springs Instrument Company | Method for quantitatively determining a particular substrate catalyzed by a multisubstrate enzyme |
| US4352960A (en) * | 1980-09-30 | 1982-10-05 | Baptist Medical Center Of Oklahoma, Inc. | Magnetic transcutaneous mount for external device of an associated implant |
| USRE32947E (en) | 1980-09-30 | 1989-06-13 | Baptist Medical Center Of Oklahoma, Inc. | Magnetic transcutaneous mount for external device of an associated implant |
| US4425920A (en) * | 1980-10-24 | 1984-01-17 | Purdue Research Foundation | Apparatus and method for measurement and control of blood pressure |
| US4390621A (en) * | 1980-12-15 | 1983-06-28 | Miles Laboratories, Inc. | Method and device for detecting glucose concentration |
| US4436094A (en) | 1981-03-09 | 1984-03-13 | Evreka, Inc. | Monitor for continuous in vivo measurement of glucose concentration |
| AT369254B (en) | 1981-05-07 | 1982-12-27 | Otto Dipl Ing Dr Tech Prohaska | MEDICAL PROBE |
| FR2508305B1 (en) | 1981-06-25 | 1986-04-11 | Slama Gerard | DEVICE FOR CAUSING A LITTLE BITE TO COLLECT A BLOOD DROP |
| US4440175A (en) | 1981-08-10 | 1984-04-03 | University Patents, Inc. | Membrane electrode for non-ionic species |
| DE3138194A1 (en) | 1981-09-25 | 1983-04-14 | Basf Ag, 6700 Ludwigshafen | WATER-INSOLUBLE POROESES PROTEIN MATERIAL, THEIR PRODUCTION AND USE |
| DE3278334D1 (en) | 1981-10-23 | 1988-05-19 | Genetics Int Inc | Sensor for components of a liquid mixture |
| US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US4418148A (en) * | 1981-11-05 | 1983-11-29 | Miles Laboratories, Inc. | Multilayer enzyme electrode membrane |
| US4494950A (en) | 1982-01-19 | 1985-01-22 | The Johns Hopkins University | Plural module medication delivery system |
| JPS58153154A (en) | 1982-03-09 | 1983-09-12 | Ajinomoto Co Inc | Qualified electrode |
| US4581336A (en) | 1982-04-26 | 1986-04-08 | Uop Inc. | Surface-modified electrodes |
| DE3221339A1 (en) | 1982-06-05 | 1983-12-08 | Basf Ag, 6700 Ludwigshafen | METHOD FOR THE ELECTROCHEMICAL HYDRATION OF NICOTINAMIDADENINE-DINUCLEOTIDE |
| US4427770A (en) * | 1982-06-14 | 1984-01-24 | Miles Laboratories, Inc. | High glucose-determining analytical element |
| EP0098592A3 (en) | 1982-07-06 | 1985-08-21 | Fujisawa Pharmaceutical Co., Ltd. | Portable artificial pancreas |
| US4534356A (en) | 1982-07-30 | 1985-08-13 | Diamond Shamrock Chemicals Company | Solid state transcutaneous blood gas sensors |
| DE3228551A1 (en) | 1982-07-30 | 1984-02-02 | Siemens AG, 1000 Berlin und 8000 München | METHOD FOR DETERMINING SUGAR CONCENTRATION |
| US4571292A (en) | 1982-08-12 | 1986-02-18 | Case Western Reserve University | Apparatus for electrochemical measurements |
| US4552840A (en) | 1982-12-02 | 1985-11-12 | California And Hawaiian Sugar Company | Enzyme electrode and method for dextran analysis |
| US4461691A (en) | 1983-02-10 | 1984-07-24 | The United States Of America As Represented By The United States Department Of Energy | Organic conductive films for semiconductor electrodes |
| US4679562A (en) | 1983-02-16 | 1987-07-14 | Cardiac Pacemakers, Inc. | Glucose sensor |
| IT1170375B (en) | 1983-04-19 | 1987-06-03 | Giuseppe Bombardieri | Implantable device for measuring body fluid parameters |
| CA1219040A (en) * | 1983-05-05 | 1987-03-10 | Elliot V. Plotkin | Measurement of enzyme-catalysed reactions |
| US5509410A (en) | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
| CA1218704A (en) * | 1983-05-05 | 1987-03-03 | Graham Davis | Assay systems using more than one enzyme |
| US4650547A (en) | 1983-05-19 | 1987-03-17 | The Regents Of The University Of California | Method and membrane applicable to implantable sensor |
| US4484987A (en) | 1983-05-19 | 1984-11-27 | The Regents Of The University Of California | Method and membrane applicable to implantable sensor |
| US4524114A (en) | 1983-07-05 | 1985-06-18 | Allied Corporation | Bifunctional air electrode |
| US4538616A (en) | 1983-07-25 | 1985-09-03 | Robert Rogoff | Blood sugar level sensing and monitoring transducer |
| US4543955A (en) | 1983-08-01 | 1985-10-01 | Cordis Corporation | System for controlling body implantable action device |
| US4655880A (en) | 1983-08-01 | 1987-04-07 | Case Western Reserve University | Apparatus and method for sensing species, substances and substrates using oxidase |
| SE8305704D0 (en) | 1983-10-18 | 1983-10-18 | Leo Ab | Cuvette |
| US4560534A (en) | 1983-11-02 | 1985-12-24 | Miles Laboratories, Inc. | Polymer catalyst transducers |
| US4522690A (en) | 1983-12-01 | 1985-06-11 | Honeywell Inc. | Electrochemical sensing of carbon monoxide |
| DE3479522D1 (en) | 1983-12-16 | 1989-09-28 | Medisense Inc | Assay for nucleic acids |
| US4684537A (en) | 1984-04-30 | 1987-08-04 | R. E. Stiftung | Process for the sensitization of an oxidation/reduction photocatalyst, and photocatalyst thus obtained |
| US5141868A (en) | 1984-06-13 | 1992-08-25 | Internationale Octrooi Maatschappij "Octropa" Bv | Device for use in chemical test procedures |
| DK8601218A (en) | 1984-07-18 | 1986-03-17 | ||
| DE3429596A1 (en) | 1984-08-10 | 1986-02-20 | Siemens AG, 1000 Berlin und 8000 München | DEVICE FOR THE PHYSIOLOGICAL FREQUENCY CONTROL OF A PACEMAKER PROVIDED WITH A PICTURE ELECTRODE |
| US4820399A (en) | 1984-08-31 | 1989-04-11 | Shimadzu Corporation | Enzyme electrodes |
| CA1254091A (en) | 1984-09-28 | 1989-05-16 | Vladimir Feingold | Implantable medication infusion system |
| US4717673A (en) | 1984-11-23 | 1988-01-05 | Massachusetts Institute Of Technology | Microelectrochemical devices |
| US4721601A (en) | 1984-11-23 | 1988-01-26 | Massachusetts Institute Of Technology | Molecule-based microelectronic devices |
| JPH0617889B2 (en) * | 1984-11-27 | 1994-03-09 | 株式会社日立製作所 | Biochemical sensor |
| EP0186210B1 (en) | 1984-12-28 | 1992-04-22 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Ion sensor |
| GB8500729D0 (en) | 1985-01-11 | 1985-02-13 | Hill H A O | Surface-modified electrode |
| EP0200321A3 (en) | 1985-03-20 | 1987-03-11 | Ingeborg J. Hochmair | Transcutaneous signal transmission system |
| US4627445A (en) | 1985-04-08 | 1986-12-09 | Garid, Inc. | Glucose medical monitoring system |
| US5279294A (en) | 1985-04-08 | 1994-01-18 | Cascade Medical, Inc. | Medical diagnostic system |
| US4781798A (en) | 1985-04-19 | 1988-11-01 | The Regents Of The University Of California | Transparent multi-oxygen sensor array and method of using same |
| US4671288A (en) | 1985-06-13 | 1987-06-09 | The Regents Of The University Of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
| EP0230472B2 (en) | 1985-06-21 | 2000-12-13 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method of manufacturing same |
| US4938860A (en) * | 1985-06-28 | 1990-07-03 | Miles Inc. | Electrode for electrochemical sensors |
| US4796634A (en) | 1985-08-09 | 1989-01-10 | Lawrence Medical Systems, Inc. | Methods and apparatus for monitoring cardiac output |
| US4805624A (en) | 1985-09-09 | 1989-02-21 | The Montefiore Hospital Association Of Western Pa | Low-potential electrochemical redox sensors |
| US4680268A (en) | 1985-09-18 | 1987-07-14 | Children's Hospital Medical Center | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
| US4890620A (en) | 1985-09-20 | 1990-01-02 | The Regents Of The University Of California | Two-dimensional diffusion glucose substrate sensing electrode |
| US4627908A (en) | 1985-10-24 | 1986-12-09 | Chevron Research Company | Process for stabilizing lube base stocks derived from bright stock |
| US4830959A (en) | 1985-11-11 | 1989-05-16 | Medisense, Inc. | Electrochemical enzymic assay procedures |
| GB8529300D0 (en) | 1985-11-28 | 1986-01-02 | Ici Plc | Membrane |
| US4776944A (en) * | 1986-03-20 | 1988-10-11 | Jiri Janata | Chemical selective sensors utilizing admittance modulated membranes |
| US4685463A (en) | 1986-04-03 | 1987-08-11 | Williams R Bruce | Device for continuous in vivo measurement of blood glucose concentrations |
| US4726378A (en) | 1986-04-11 | 1988-02-23 | Minnesota Mining And Manufacturing Company | Adjustable magnetic supercutaneous device and transcutaneous coupling apparatus |
| US4994167A (en) | 1986-04-15 | 1991-02-19 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
| US4757022A (en) | 1986-04-15 | 1988-07-12 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
| US4909908A (en) | 1986-04-24 | 1990-03-20 | Pepi Ross | Electrochemical cncentration detector method |
| DE3614821A1 (en) | 1986-05-02 | 1987-11-05 | Siemens Ag | IMPLANTABLE, CALIBRABLE MEASURING DEVICE FOR A BODY SUBSTANCE AND CALIBRATION METHOD |
| US4703756A (en) | 1986-05-06 | 1987-11-03 | The Regents Of The University Of California | Complete glucose monitoring system with an implantable, telemetered sensor module |
| US4731726A (en) | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
| GB8612861D0 (en) | 1986-05-27 | 1986-07-02 | Cambridge Life Sciences | Immobilised enzyme biosensors |
| US4969468A (en) | 1986-06-17 | 1990-11-13 | Alfred E. Mann Foundation For Scientific Research | Electrode array for use in connection with a living body and method of manufacture |
| US4911794A (en) | 1986-06-20 | 1990-03-27 | Molecular Devices Corporation | Measuring with zero volume cell |
| US5001054A (en) | 1986-06-26 | 1991-03-19 | Becton, Dickinson And Company | Method for monitoring glucose |
| JPS636451A (en) * | 1986-06-27 | 1988-01-12 | Terumo Corp | Enzyme sensor |
| US4764416A (en) | 1986-07-01 | 1988-08-16 | Mitsubishi Denki Kabushiki Kaisha | Electric element circuit using oxidation-reduction substances |
| US4917800A (en) | 1986-07-07 | 1990-04-17 | Bend Research, Inc. | Functional, photochemically active, and chemically asymmetric membranes by interfacial polymerization of derivatized multifunctional prepolymers |
| US4784736A (en) | 1986-07-07 | 1988-11-15 | Bend Research, Inc. | Functional, photochemically active, and chemically asymmetric membranes by interfacial polymerization of derivatized multifunctional prepolymers |
| US4726716A (en) | 1986-07-21 | 1988-02-23 | Mcguire Thomas V | Fastener for catheter |
| US4894137A (en) | 1986-09-12 | 1990-01-16 | Omron Tateisi Electronics Co. | Enzyme electrode |
| US4897162A (en) | 1986-11-14 | 1990-01-30 | The Cleveland Clinic Foundation | Pulse voltammetry |
| DE3700119A1 (en) | 1987-01-03 | 1988-07-14 | Inst Diabetestechnologie Gemei | IMPLANTABLE ELECTROCHEMICAL SENSOR |
| US4934369A (en) | 1987-01-30 | 1990-06-19 | Minnesota Mining And Manufacturing Company | Intravascular blood parameter measurement system |
| GB2201248B (en) | 1987-02-24 | 1991-04-17 | Ici Plc | Enzyme electrode sensors |
| US5002054A (en) | 1987-02-25 | 1991-03-26 | Ash Medical Systems, Inc. | Interstitial filtration and collection device and method for long-term monitoring of physiological constituents of the body |
| US4854322A (en) | 1987-02-25 | 1989-08-08 | Ash Medical Systems, Inc. | Capillary filtration and collection device for long-term monitoring of blood constituents |
| US4777953A (en) | 1987-02-25 | 1988-10-18 | Ash Medical Systems, Inc. | Capillary filtration and collection method for long-term monitoring of blood constituents |
| US4848351A (en) | 1987-03-04 | 1989-07-18 | Sentry Medical Products, Inc. | Medical electrode assembly |
| US4923586A (en) | 1987-03-31 | 1990-05-08 | Daikin Industries, Ltd. | Enzyme electrode unit |
| US4935345A (en) | 1987-04-07 | 1990-06-19 | Arizona Board Of Regents | Implantable microelectronic biochemical sensor incorporating thin film thermopile |
| US4759828A (en) | 1987-04-09 | 1988-07-26 | Nova Biomedical Corporation | Glucose electrode and method of determining glucose |
| US5352348A (en) | 1987-04-09 | 1994-10-04 | Nova Biomedical Corporation | Method of using enzyme electrode |
| US4749985A (en) | 1987-04-13 | 1988-06-07 | United States Of America As Represented By The United States Department Of Energy | Functional relationship-based alarm processing |
| EP0290683A3 (en) | 1987-05-01 | 1988-12-14 | Diva Medical Systems B.V. | Diabetes management system and apparatus |
| US5286364A (en) | 1987-06-08 | 1994-02-15 | Rutgers University | Surface-modified electochemical biosensor |
| US4822337A (en) | 1987-06-22 | 1989-04-18 | Stanley Newhouse | Insulin delivery method and apparatus |
| JPH07122624B2 (en) | 1987-07-06 | 1995-12-25 | ダイキン工業株式会社 | Biosensor |
| US4874500A (en) | 1987-07-15 | 1989-10-17 | Sri International | Microelectrochemical sensor and sensor array |
| GB8718430D0 (en) * | 1987-08-04 | 1987-09-09 | Ici Plc | Sensor |
| JPS6423155A (en) | 1987-07-17 | 1989-01-25 | Daikin Ind Ltd | Electrode refreshing device for biosensor |
| US5135003A (en) | 1987-08-11 | 1992-08-04 | Terumo Kabushiki Kaisha | Automatic sphygmomanometer |
| US4974929A (en) | 1987-09-22 | 1990-12-04 | Baxter International, Inc. | Fiber optical probe connector for physiologic measurement devices |
| NL8702370A (en) | 1987-10-05 | 1989-05-01 | Groningen Science Park | METHOD AND SYSTEM FOR GLUCOSE DETERMINATION AND USEABLE MEASURING CELL ASSEMBLY. |
| US4815469A (en) | 1987-10-08 | 1989-03-28 | Siemens-Pacesetter, Inc. | Implantable blood oxygen sensor and method of use |
| GB8725936D0 (en) | 1987-11-05 | 1987-12-09 | Genetics Int Inc | Sensing system |
| JPH01140054A (en) * | 1987-11-26 | 1989-06-01 | Nec Corp | Glucose sensor |
| US4813424A (en) | 1987-12-23 | 1989-03-21 | University Of New Mexico | Long-life membrane electrode for non-ionic species |
| US5108564A (en) | 1988-03-15 | 1992-04-28 | Tall Oak Ventures | Method and apparatus for amperometric diagnostic analysis |
| EP0359831B2 (en) | 1988-03-31 | 2007-06-20 | Matsushita Electric Industrial Co., Ltd. | Biosensor and process for its production |
| GB8817421D0 (en) | 1988-07-21 | 1988-08-24 | Medisense Inc | Bioelectrochemical electrodes |
| US4925268A (en) | 1988-07-25 | 1990-05-15 | Abbott Laboratories | Fiber-optic physiological probes |
| US4954129A (en) | 1988-07-25 | 1990-09-04 | Abbott Laboratories | Hydrodynamic clot flushing |
| EP0353328A1 (en) | 1988-08-03 | 1990-02-07 | Dräger Nederland B.V. | A polarographic-amperometric three-electrode sensor |
| US5340722A (en) | 1988-08-24 | 1994-08-23 | Avl Medical Instruments Ag | Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method |
| US5264106A (en) | 1988-10-07 | 1993-11-23 | Medisense, Inc. | Enhanced amperometric sensor |
| US4995402A (en) | 1988-10-12 | 1991-02-26 | Thorne, Smith, Astill Technologies, Inc. | Medical droplet whole blood and like monitoring |
| US5205920A (en) | 1989-03-03 | 1993-04-27 | Noboru Oyama | Enzyme sensor and method of manufacturing the same |
| US5089112A (en) | 1989-03-20 | 1992-02-18 | Associated Universities, Inc. | Electrochemical biosensor based on immobilized enzymes and redox polymers |
| US4953552A (en) | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
| EP0396788A1 (en) | 1989-05-08 | 1990-11-14 | Dräger Nederland B.V. | Process and sensor for measuring the glucose content of glucosecontaining fluids |
| US5198367A (en) | 1989-06-09 | 1993-03-30 | Masuo Aizawa | Homogeneous amperometric immunoassay |
| FR2648353B1 (en) | 1989-06-16 | 1992-03-27 | Europhor Sa | MICRODIALYSIS PROBE |
| CH677149A5 (en) * | 1989-07-07 | 1991-04-15 | Disetronic Ag | |
| US4986271A (en) | 1989-07-19 | 1991-01-22 | The University Of New Mexico | Vivo refillable glucose sensor |
| US5264104A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
| US5320725A (en) | 1989-08-02 | 1994-06-14 | E. Heller & Company | Electrode and method for the detection of hydrogen peroxide |
| US5262035A (en) | 1989-08-02 | 1993-11-16 | E. Heller And Company | Enzyme electrodes |
| US5264105A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
| US4944299A (en) | 1989-08-08 | 1990-07-31 | Siemens-Pacesetter, Inc. | High speed digital telemetry system for implantable device |
| US5190041A (en) | 1989-08-11 | 1993-03-02 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
| US5101814A (en) | 1989-08-11 | 1992-04-07 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
| US5095904A (en) | 1989-09-08 | 1992-03-17 | Cochlear Pty. Ltd. | Multi-peak speech procession |
| FR2652736A1 (en) | 1989-10-06 | 1991-04-12 | Neftel Frederic | IMPLANTABLE DEVICE FOR EVALUATING THE RATE OF GLUCOSE. |
| EP0429076B1 (en) | 1989-11-24 | 1996-01-31 | Matsushita Electric Industrial Co., Ltd. | Preparation of biosensor |
| US5082550A (en) | 1989-12-11 | 1992-01-21 | The United States Of America As Represented By The Department Of Energy | Enzyme electrochemical sensor electrode and method of making it |
| US5342789A (en) | 1989-12-14 | 1994-08-30 | Sensor Technologies, Inc. | Method and device for detecting and quantifying glucose in body fluids |
| EP0505494B1 (en) | 1989-12-15 | 1995-07-12 | Boehringer Mannheim Corporation | Redox mediator reagent and biosensor |
| US5286362A (en) | 1990-02-03 | 1994-02-15 | Boehringer Mannheim Gmbh | Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor |
| US5109850A (en) | 1990-02-09 | 1992-05-05 | Massachusetts Institute Of Technology | Automatic blood monitoring for medication delivery method and apparatus |
| US5165407A (en) | 1990-04-19 | 1992-11-24 | The University Of Kansas | Implantable glucose sensor |
| US5161532A (en) | 1990-04-19 | 1992-11-10 | Teknekron Sensor Development Corporation | Integral interstitial fluid sensor |
| US5288387A (en) * | 1990-06-12 | 1994-02-22 | Daikin Industries, Ltd. | Apparatus for maintaining the activity of an enzyme electrode |
| US5250439A (en) | 1990-07-19 | 1993-10-05 | Miles Inc. | Use of conductive sensors in diagnostic assays |
| US5202261A (en) | 1990-07-19 | 1993-04-13 | Miles Inc. | Conductive sensors and their use in diagnostic assays |
| US5058592A (en) | 1990-11-02 | 1991-10-22 | Whisler G Douglas | Adjustable mountable doppler ultrasound transducer device |
| FR2673289B1 (en) | 1991-02-21 | 1994-06-17 | Asulab Sa | SENSOR FOR MEASURING THE QUANTITY OF A COMPONENT IN SOLUTION. |
| US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
| US5262305A (en) * | 1991-03-04 | 1993-11-16 | E. Heller & Company | Interferant eliminating biosensors |
| JPH04278450A (en) | 1991-03-04 | 1992-10-05 | Adam Heller | Biosensor and method for analyzing subject |
| US5208154A (en) | 1991-04-08 | 1993-05-04 | The United States Of America As Represented By The Department Of Energy | Reversibly immobilized biological materials in monolayer films on electrodes |
| US5192416A (en) | 1991-04-09 | 1993-03-09 | New Mexico State University Technology Transfer Corporation | Method and apparatus for batch injection analysis |
| US5293546A (en) | 1991-04-17 | 1994-03-08 | Martin Marietta Corporation | Oxide coated metal grid electrode structure in display devices |
| JP3118015B2 (en) | 1991-05-17 | 2000-12-18 | アークレイ株式会社 | Biosensor and separation and quantification method using the same |
| US5209229A (en) | 1991-05-20 | 1993-05-11 | Telectronics Pacing Systems, Inc. | Apparatus and method employing plural electrode configurations for cardioversion of atrial fibrillation in an arrhythmia control system |
| JP2816262B2 (en) | 1991-07-09 | 1998-10-27 | 工業技術院長 | Carbon microsensor electrode and method of manufacturing the same |
| GB9120144D0 (en) | 1991-09-20 | 1991-11-06 | Imperial College | A dialysis electrode device |
| US5322063A (en) | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
| US5264103A (en) | 1991-10-18 | 1993-11-23 | Matsushita Electric Industrial Co., Ltd. | Biosensor and a method for measuring a concentration of a substrate in a sample |
| US5217595A (en) | 1991-10-25 | 1993-06-08 | The Yellow Springs Instrument Company, Inc. | Electrochemical gas sensor |
| US5415164A (en) | 1991-11-04 | 1995-05-16 | Biofield Corp. | Apparatus and method for screening and diagnosing trauma or disease in body tissues |
| US5271815A (en) * | 1991-12-26 | 1993-12-21 | Via Medical Corporation | Method for measuring glucose |
| US5285792A (en) | 1992-01-10 | 1994-02-15 | Physio-Control Corporation | System for producing prioritized alarm messages in a medical instrument |
| US5246867A (en) | 1992-01-17 | 1993-09-21 | University Of Maryland At Baltimore | Determination and quantification of saccharides by luminescence lifetimes and energy transfer |
| NL9200207A (en) | 1992-02-05 | 1993-09-01 | Nedap Nv | IMPLANTABLE BIOMEDICAL SENSOR DEVICE, IN PARTICULAR FOR MEASUREMENT OF THE GLUCOSE CONCENTRATION. |
| GB9211402D0 (en) | 1992-05-29 | 1992-07-15 | Univ Manchester | Sensor devices |
| US5421816A (en) | 1992-10-14 | 1995-06-06 | Endodermic Medical Technologies Company | Ultrasonic transdermal drug delivery system |
| US5387327A (en) | 1992-10-19 | 1995-02-07 | Duquesne University Of The Holy Ghost | Implantable non-enzymatic electrochemical glucose sensor |
| US5320098A (en) | 1992-10-20 | 1994-06-14 | Sun Microsystems, Inc. | Optical transdermal link |
| WO1994010553A1 (en) | 1992-10-23 | 1994-05-11 | Optex Biomedical, Inc. | Fibre-optic probe for the measurement of fluid parameters |
| US5899855A (en) * | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
| ZA938555B (en) | 1992-11-23 | 1994-08-02 | Lilly Co Eli | Technique to improve the performance of electrochemical sensors |
| DK148592D0 (en) * | 1992-12-10 | 1992-12-10 | Novo Nordisk As | APPARATUS |
| FR2701117B1 (en) | 1993-02-04 | 1995-03-10 | Asulab Sa | Electrochemical measurement system with multizone sensor, and its application to glucose measurement. |
| DE4318519C2 (en) * | 1993-06-03 | 1996-11-28 | Fraunhofer Ges Forschung | Electrochemical sensor |
| DE4329898A1 (en) * | 1993-09-04 | 1995-04-06 | Marcus Dr Besson | Wireless medical diagnostic and monitoring device |
| US5582184A (en) | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
| US5497772A (en) | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
| US5791344A (en) * | 1993-11-19 | 1998-08-11 | Alfred E. Mann Foundation For Scientific Research | Patient monitoring system |
| US5589326A (en) | 1993-12-30 | 1996-12-31 | Boehringer Mannheim Corporation | Osmium-containing redox mediator |
| US5437999A (en) | 1994-02-22 | 1995-08-01 | Boehringer Mannheim Corporation | Electrochemical sensor |
| US5390671A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Transcutaneous sensor insertion set |
| US5391250A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
| US5569186A (en) | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
| JP3061351B2 (en) | 1994-04-25 | 2000-07-10 | 松下電器産業株式会社 | Method and apparatus for quantifying specific compounds |
| DE4415896A1 (en) | 1994-05-05 | 1995-11-09 | Boehringer Mannheim Gmbh | Analysis system for monitoring the concentration of an analyte in the blood of a patient |
| US5545191A (en) | 1994-05-06 | 1996-08-13 | Alfred E. Mann Foundation For Scientific Research | Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body |
| US5494562A (en) | 1994-06-27 | 1996-02-27 | Ciba Corning Diagnostics Corp. | Electrochemical sensors |
| US5568806A (en) | 1995-02-16 | 1996-10-29 | Minimed Inc. | Transcutaneous sensor insertion set |
| US5586553A (en) | 1995-02-16 | 1996-12-24 | Minimed Inc. | Transcutaneous sensor insertion set |
| US5651869A (en) | 1995-02-28 | 1997-07-29 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
| US5596150A (en) | 1995-03-08 | 1997-01-21 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Capacitance probe for fluid flow and volume measurements |
| JPH08247987A (en) * | 1995-03-15 | 1996-09-27 | Omron Corp | Portable measuring instrument |
| US5582697A (en) | 1995-03-17 | 1996-12-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
| US5628310A (en) | 1995-05-19 | 1997-05-13 | Joseph R. Lakowicz | Method and apparatus to perform trans-cutaneous analyte monitoring |
| IL122427A0 (en) | 1995-06-07 | 1998-06-15 | Sugen Inc | Pharmaceutical compositions and methods for inhibition of adaptor protein/tyrosine kinase interactions |
| US5567302A (en) | 1995-06-07 | 1996-10-22 | Molecular Devices Corporation | Electrochemical system for rapid detection of biochemical agents that catalyze a redox potential change |
| US5995860A (en) * | 1995-07-06 | 1999-11-30 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
| US5682233A (en) * | 1995-09-08 | 1997-10-28 | Integ, Inc. | Interstitial fluid sampler |
| US5628890A (en) | 1995-09-27 | 1997-05-13 | Medisense, Inc. | Electrochemical sensor |
| US5741211A (en) * | 1995-10-26 | 1998-04-21 | Medtronic, Inc. | System and method for continuous monitoring of diabetes-related blood constituents |
| US5711861A (en) * | 1995-11-22 | 1998-01-27 | Ward; W. Kenneth | Device for monitoring changes in analyte concentration |
| US5708247A (en) * | 1996-02-14 | 1998-01-13 | Selfcare, Inc. | Disposable glucose test strips, and methods and compositions for making same |
| EP0914178B1 (en) | 1996-06-18 | 2003-03-12 | Alza Corporation | Device for enhancing transdermal agent delivery or sampling |
| US5964993A (en) * | 1996-12-19 | 1999-10-12 | Implanted Biosystems Inc. | Glucose sensor |
| US6093172A (en) | 1997-02-05 | 2000-07-25 | Minimed Inc. | Injector for a subcutaneous insertion set |
| US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
| US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
| US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US6497729B1 (en) | 1998-11-20 | 2002-12-24 | The University Of Connecticut | Implant coating for control of tissue/implant interactions |
| US6360888B1 (en) | 1999-02-25 | 2002-03-26 | Minimed Inc. | Glucose sensor package system |
| US6285897B1 (en) | 1999-04-07 | 2001-09-04 | Endonetics, Inc. | Remote physiological monitoring system |
| US6669663B1 (en) | 1999-04-30 | 2003-12-30 | Medtronic, Inc. | Closed loop medicament pump |
| US6974437B2 (en) | 2000-01-21 | 2005-12-13 | Medtronic Minimed, Inc. | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| WO2006127694A2 (en) * | 2004-07-13 | 2006-11-30 | Dexcom, Inc. | Analyte sensor |
-
1991
- 1991-08-27 JP JP3238928A patent/JPH04278450A/en active Pending
- 1991-08-27 CA CA002050057A patent/CA2050057A1/en not_active Abandoned
-
1993
- 1993-12-02 US US08/161,682 patent/US5356786A/en not_active Expired - Lifetime
-
2008
- 2008-02-28 US US12/039,576 patent/US20080210557A1/en not_active Abandoned
- 2008-11-12 US US12/269,800 patent/US8414749B2/en not_active Expired - Fee Related
-
2010
- 2010-09-29 US US12/893,788 patent/US8414750B2/en not_active Expired - Fee Related
-
2012
- 2012-01-05 US US13/344,402 patent/US20120108930A1/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0652436A2 (en) * | 1993-11-04 | 1995-05-10 | Lg Electronics Inc. | Bio-sensor for measuring alcohol concentration, method for manufacturing the bio-sensor and drunkometer using the same |
| EP0652436A3 (en) * | 1993-11-04 | 1997-04-02 | Gold Star Co | Bio-sensor for measuring alcohol concentration, method for manufacturing the bio-sensor and drunkometer using the same. |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04278450A (en) | 1992-10-05 |
| US8414750B2 (en) | 2013-04-09 |
| US20090137889A1 (en) | 2009-05-28 |
| US5356786A (en) | 1994-10-18 |
| US8414749B2 (en) | 2013-04-09 |
| US20080210557A1 (en) | 2008-09-04 |
| US20110021895A1 (en) | 2011-01-27 |
| US20120108930A1 (en) | 2012-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2050057A1 (en) | Interferant eliminating biosensors | |
| US5262305A (en) | Interferant eliminating biosensors | |
| JP3242923B2 (en) | Electrode and method for detecting hydrogen peroxide | |
| CA2045616C (en) | Enzyme electrochemical sensor electrode and method of making it | |
| Karyakin et al. | Prussian blue-based first-generation biosensor. A sensitive amperometric electrode for glucose | |
| Guerrieri et al. | Electrosynthesized non-conducting polymers as permselective membranes in amperometric enzyme electrodes: a glucose biosensor based on a co-crosslinked glucose oxidase/overoxidized polypyrrole bilayer | |
| US8758591B2 (en) | Electrochemical nanocomposite biosensor system | |
| US4127448A (en) | Amperometric-non-enzymatic method of determining sugars and other polyhydroxy compounds | |
| Vidal et al. | A chronoamperometric sensor for hydrogen peroxide based on electron transfer between immobilized horseradish peroxidase on a glassy carbon electrode and a diffusing ferrocene mediator | |
| Nakabayashi et al. | Amperometric biosensors for sensing of hydrogen peroxide based on electron transfer between horseradish peroxidase and ferrocene as a mediator | |
| Nieh et al. | Amperometric biosensor based on reductive H2O2 detection using pentacyanoferrate-bound polymer for creatinine determination | |
| Nakabayashi et al. | Amperometric glucose sensors fabricated by electrochemical polymerization of phenols on carbon paste electrodes containing ferrocene as an electron transfer mediator | |
| Quan et al. | Amperometric detection of catechol and catecholamines by immobilized laccase from DeniLite | |
| US20150276652A1 (en) | Analysis Device | |
| Bardeletti et al. | Amperometric enzyme electrodes for substrate and enzyme activity determinations | |
| US7169273B2 (en) | Enzyme electrode | |
| Xu et al. | Glucose biosensors prepared by electropolymerization of p-chlorophenylamine with and without Nafion | |
| Klemm et al. | An enzymic method for the determination of bilirubin using an oxygen electrode | |
| Deng et al. | Self-gelatinizable copolymer immobilized glucose biosensor based on Prussian Blue modified graphite electrode | |
| US4220503A (en) | Stabilization of activated galactose oxidase enzyme | |
| Bartlett et al. | Electrochemical immobilization of enzymes. Part VI. Microelectrodes for the detection of L-lactate based on flavocytochrome b 2 immobilized in a poly (phenol) film | |
| Cooper et al. | Biomolecular sensors for neurotransmitter determination: electrochemical immobilization of glutamate oxidase at microelectrodes in a poly (o-phenylenediamine) film | |
| Ferri et al. | A Glucose Biosensor Based on Electro‐Enzyme Catalyzed Oxidation of Glucose Using a HRP‐GOD Layered Assembly | |
| EP0300082A2 (en) | Enzyme electrode | |
| Ivanov et al. | New polyaniline-based potentiometric biosensor for pesticides detection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |